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Heparan sulfate proteoglycans (HSPGs) are biologically relevant molecules 
composed of core proteins and glycosaminoglycan (GAG) chains.  The location of 
HSPGs, on the cell surface or in the extracellular matrix, and their structural 
heterogeneity place them at a unique advantage to influence signaling pathways and cell-
cell or cell-matrix interactions.  Most of the genes that code for the core proteins and the 
enzymes that build and modify the GAG chains have been identified.  One type of 
modification, 3-O-sulfation, is catalyzed by a family of 3-O-sulfotransferases (3-OSTs) in 
zebrafish.  Gene expression studies suggest they could modulate different steps of 
zebrafish development, but the specific roles of each 3-OST have not been elucidated.   
My dissertation focused on the functions a particular 3-OST, 3-OST-7, perform in 
zebrafish heart development.    
To elucidate the functions of 3-OST-7 in zebrafish heart development, I knocked 
down 3-OST-7 using morpholinos and found that 3-OST-7 controls ventricular 
contraction.  Analysis of the noncontracting ventricle phenotype in 3-OST-7 morphants 
demonstrated that tropomyosin4 is required to mediate 3-OST-7 regulation of ventricular 
contraction, placing 3-OST-7 upstream of a novel pathway that controls coordinated 
sarcomere assembly.  
Further analysis of the 3-OST-7 knockdown model illustrated that 3-OST-7 
functions in two distinct pathways that regulate ventricular maturation.  First, 3-OST-7 is 
!! "#!
necessary for transforming the isometric ventricular cardiomyocytes into their elongated 
form.  Second, 3-OST-7 shares a feedback loop with bmp4 signaling to regulate 
contraction.  These findings demonstrated the specificity of 3-OST-7 action towards 
influencing cardiac development. 
Moreover, these studies highlighted the strength of the 3-OST-7 knockdown 
model in teasing apart the relationship between structure and function.  I anticipate that 
further investigation of this model could advance our understanding of the 
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CHAPTER 1 
 INTRODUCTION  
Vertebrate heart development is a complex process that involves precise 
coordination of patterning events and cell movements in order to generate a fully formed 
and functional heart.  A molecular framework has emerged that elucidates the 
commitment of exclusive lineages to discrete regions of the heart, and the underlying 
cellular decisions that direct the three-dimensional events of cardiac formation.  Despite 
these advances in our understanding of heart development, critical questions remain in 
the field and unknown players remain to be discovered.  Answering these questions and 
identifying these players could lead to significant advances in the ability to repair or 
regenerate damaged cardiac tissue via stem cell therapy, and in the ability to diagnose 
and correct devastating human heart malformations. 
What is exceptional about the process of cardiac formation is that the heart begins 
to function while it continues to develop, and in doing so, shapes its own development.  
This provides a unique and excellent model for studying not only how form affects 
function, but how function affects form as well.  The relationship between form and 
function of the heart has been of considerable interest, particularly to those studying late-
onset or acquired cardiac diseases, such as the cardiomyopathies.  Studies in this area 
have shown that poor myocardial function causes the heart to compensate by remodeling.  
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This dissertation will examine the relationship between form and function of the 
heart during its early stages of development.   It will also focus on the patterning and 
formation of the heart’s contractile chambers in zebrafish and examine how this occurs in 
the context of biologically relevant modifications on heparan sulfate proteoglycans.  This 
will hopefully promote a deeper understanding of heart development and a greater 
appreciation of its stunning intricacies. 
Overview of vertebrate heart development 
 Studies in different model organisms have demonstrated a program of heart 
development that has been conserved throughout evolution.  The cells of the developing 
heart come from two distinct mesodermal heart fields that arise and segregate from a 
common origin (Kelly et al., 2001; Cai et al., 2003; Abu-Issa et al., 2004).  The well-
studied primary heart field (PHF) originates from cells in the anterior lateral plate 
mesoderm (LPM) (Srivastava, 2006).  The cells of the PHF migrate to coalesce along the 
ventral midline forming a primitive linear heart tube consisting of an inner endocardial 
layer and an outer myocardial layer, separated by extracellular matrix (Garry and Olson, 
2006).  The tube then undergoes morphogenetic movements and differential growth that 
result in rightward looping and chamber formation (Buckingham et al., 2005).  The 
secondary heart field (SHF) originates from the pharyngeal mesoderm located medial to 
the PHF (Garry and Olson, 2006).  Cells from the SHF begin migrating to the midline 
when the tube is forming and position themselves dorsal to the heart tube (Srivastava, 
2006).  When the heart tube starts looping to the right, the SHF migrates to the anterior 
and posterior portions of the tube, contributing primarily to the outflow tract (OFT) and 
right ventricle (Kelly et al., 2001; Cai et al., 2003; Laugwitz et al., 2005). 
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 In addition to possessing certain features that make zebrafish especially suitable 
for investigating cardiac formation (Stainier and Fishman, 1994), the early stages of its 
heart development are highly conserved with a few minor differences.  In zebrafish the 
PHF appears as bilateral sheets similar to those seen in chick, but in contrast to the 
cardiac crescent formed in mouse (Stalsberg and DeHaan, 1969; Parameswaran and Tam, 
1995; Yelon et al., 1999).  These bilateral sheets in zebrafish migrate to the midline, 
where they fuse and form a cardiac cone (Yelon et al., 1999).  This cone gradually 
elongates to form the primitive heart tube.  The heart tube transforms into a two-
chambered organ between 24 hours postfertilization (hpf) and 48 hpf through the 
processes of looping, constriction at the atrioventricular canal (AVC), and bulging of the 
chambers (Auman et al., 2007). The SHF in zebrafish is not as well studied as in chick 
and mouse, but it has been observed that new, late-differentiating cardiomyocytes are 
added to the arterial and venous poles of the heart between 24 hpf and 48 hpf (de Pater et 
al., 2009).    
Myocardial development - specification 
 The term specification refers to the period where patterning and growth of 
undifferentiated cardiomyocyte precursors occur.  In zebrafish, specification begins 
during gastrulation, as suggested by pharmacological inhibition of the FGF, BMP, and 
Hedgehog signaling pathways, which have been shown to be important in this early step 
of cardiac development (Marques et al., 2008; Thomas et al., 2008; Marques and Yelon, 
2009).  After gastrulation, molecular markers including nkx2.5, tbx5, tbx20, gata4, gata5, 
gata6, and hand2 can be used to identify the heart field in the LPM (Evans et al., 2010).  
As these markers are also expressed in neighboring, noncardiac tissue or only in a subset 
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of cardiac precursors, it is necessary to use these markers combinatorially to define the 
location of the heart field (Raffin et al., 2000; Schoenebeck et al., 2007). 
 The BMP, FGF, and Nodal pathways have been shown to provide key signals that 
specify the myocardial fate.  Zebrafish mutants for members of these pathways such as 
bmp2b/swirl, fgf8/ace, and oep have reduced numbers of cardiomyocytes correlated with 
reduced expression of cardiac lineage markers such as nkx2.5 (Reifers et al., 2000; Reiter 
et al., 2001).  Likewise, smoothened mutants, which exhibit perturbed Hedgehog 
signaling, also have decreased numbers of myocardial precursors (Thomas et al., 2008).  
In contrast to these pathways that positively reinforce cardiac specification, pathways 
involved in endothelial and hematopoietic specification have been shown to restrict it.   
Fate mapping studies in zebrafish mutants lacking vessel and blood lineages 
demonstrated that their enlarged hearts and ectopic cardiomyocytes result from 
transformation of mesodermal regions known to give rise to vessel and blood lineages 
(Schoenebeck et al., 2007).  Together these studies suggest these signals are integrated in 
the heart field for commitment to the cardiac lineage.  How they are integrated remains 
largely unknown.  
Myocardial development - differentiation 
 Differentiation is defined by the subspecialization of specified myocardial 
precursors and is accompanied by downregulation of proliferative pathways and 
upregulation of differentiation pathways.  Discussion of this topic is subdivided into a 
general overview of pathways involved in early stages of differentiation, a look at 
myofibrillogenesis and generation of the heartbeat, and finally focusing on the 
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importance of delineating chamber from nonchamber myocardium in the steps of cardiac 
maturation. 
Pathways regulating early stages of differentiation 
It has been demonstrated that differentiation is mediated by BMP signaling, the 
activity of the T-box (Tbx) family of transcription factors, canonical and noncanonical 
Wnt signaling, and Hedgehog signaling (Evans et al., 2010).  In Xenopus, expression of a 
dominant-negative activin-like kinase 3 receptor inhibited expression of differentiation 
markers (Shi et al., 2000; Walters et al., 2001; Yang et al., 2006).  Furthermore, BMP 
signaling has been shown to be required for maintaining tbx20 expression in the 
developing heart (Mandel et al., 2010). 
 Knockout or knockdown of tbx20 in different animal models causes a progressive 
loss of cardiomyocytes, and defects in looping, chamber formation and maturation 
(Brown et al., 2005; Cai et al., 2005; Singh et al., 2005; Stennard et al., 2005), 
highlighting its importance in cardiac differentiation.  In contrast to tbx20, tbx1 
negatively regulates differentiation.  Ectopic expression of differentiation genes including 
raldh2, gata4, and tbx5 and a subset of muscle contractile genes occurs in tbx1-null mice 
(Liao et al., 2008). 
 Similar to the contrasting activity of tbx20 and tbx1, the canonical and non-
canonical Wnt signaling pathways appear to have opposing actions on differentiation.  
Constitutive activation of !-catenin in SHF precursors, where it has been shown to be 
important in proliferation, inhibits differentiation (Ai et al., 2007; Cohen et al., 2007; 
Kwon et al., 2007; Qyang et al., 2007).  Despite this role of !-catenin in proliferation, it 
can also activate Wnt11, which signals through the noncanonical pathway and regulates 
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an important facet of cardiac differentiation, cell polarity (Phillips et al., 2005; Zhou et 
al., 2007).  Hedgehog signaling is another pathway that needs to be downregulated. SHF-
specific ablation of the smoothened receptor results in premature differentiation in mouse 
(Goddeeris et al., 2008).   
In summary, these pathways act in concert or in an antagonistic fashion to 
promote cardiac differentiation.  It remains to be explored how these pathways are 
orchestrated to promote a single fate, that of the mature and functional heart, and to know 
the identity of the players that direct these activities.   Furthermore, most of these studies 
were done in mouse and it would be interesting to know whether they hold true in 
zebrafish as well.   
Myofibrillogenesis 
An important aspect of differentiation is the expression and assembly of proteins 
directly linked to the function of the heart.  For the heart to contract, contractile proteins 
must be produced and assembled in units called sarcomeres.  This process termed 
myofibrillogenesis gives rise to a sarcomere that is composed of a thick filament system, 
composed mostly of myosin, and a thin filament system, consisting of actin, troponin, 
and tropomyosin.  This highly organized structure ensures coordinated generation of 
force by regulating interaction of actin and myosin filaments.  Thus, it is without surprise 
that mutations in many sarcomeric genes are found in human patients with 
cardiomyopathies (Clark et al., 2002).   
Systematic genetic studies of sarcomeric genes in an in vivo model are lacking, 
however there are several models of myofibrillogenesis (Sanger et al., 2005; Boateng and 
Goldspink, 2008).  In the first model, a stress-fiber like structure serves as the framework 
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for subsequent sarcomere assembly (Dlugosz et al., 1984).  The second model proposes 
that thick and thin filaments are first assembled independently before being joined 
together to form a myofibril (Schultheiss et al., 1990; Holtzer et al., 1997; Ojima et al., 
1999).  The third model stresses that myofibrils arise from preexisting myofibrils along 
the cell membrane (Rhee et al., 1994; Dabiri et al., 1997).  These preexisting myofibrils 
are shorter versions of the mature sarcomere and lengthen only when titin binds them (Du 
et al., 2003; Du et al., 2008).  Unlike these three models, the fourth model proposes that 
sarcomere assembly is a concurrent event without the need for intermediate structures 
(Ehler et al., 1999; Ehler et al., 2004).  A study in zebrafish using immunohistochemistry 
to visualize sarcomere proteins supported the first three models, observed at different 
assembly steps during myobrillogenesis (Huang et al., 2009).   
Large-scale mutagenesis screens in zebrafish have yielded several mutations for 
sarcomere genes that affect contraction including cardiac troponin T, titin, atrial myosin 
heavy chain, cardiac myosin light chain 2, and tropomyosin 4 (Sehnert et al., 2002; Xu et 
al., 2002; Berdougo et al., 2003; Rottbauer et al., 2006; Zhao et al., 2008).  Some of these 
studies demonstrated that loss of a sarcomere protein impacts on the stability of other 
sarcomere proteins and the sarcomere as a whole (Sehnert et al., 2002; Zhao et al., 2008).  
Together these studies establish the importance of a properly assembled sarcomere for 
normal heart contraction. 
Generation of heartbeat 
Generation of the heartbeat can be analyzed in the context of the process of 
excitation-contraction coupling.   This is a physiological process whereby an electrical 
stimulus (action potential) is converted to a mechanical response (contraction) (Stern, 
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1992).  Electrical stimulus initiates a sequence of events involving the influx and efflux 
of various ions resulting in an action potential and a depolarized membrane.  Ca2+ ions 
which enter the cell during these events positively reinforce the subsequent release of 
more calcium ions from the sarcoplasmic reticulum (SR) (Bers, 2002).  Ca2+ then binds 
the troponin C subunit (TnC) of the cardiac troponin complex (Gordon et al., 2001).  This 
upregulates the interaction between TnC and another troponin subunit, TnI, resulting in 
reduced interaction between TnI and actin (Tobacman, 1996; Solaro and Rarick, 1998).  
Once TnI and actin detach from each other, tropomyosin moves over actin uncovering the 
myosin binding sites (Vibert et al., 1997; Gordon et al., 2001).  Myosin binds and pulls 
actin towards the center of the sarcomere, effectively shortening the sarcomere and 
generating contraction. 
These events highlight the importance not only of the sarcomere in generating the 
heartbeat, but also the requirement for upstream players that couple excitation and 
contraction.  This includes, but is not limited to, the plasma membrane ion channels that 
allow influx and efflux of Na+, K+, and Ca2+ ions, and the SR membrane calcium 
channels that mediate release and re-uptake of Ca2+ ions. 
Another important aspect of a functional heartbeat is for atrial or ventricular 
cardiomyocytes to undergo coordinated contraction and this occurs by conduction of the 
electrical signal to adjacent cells.  Electrical stimulation is initiated by pacemaker cells in 
the sinoatrial (SA) node.  This stimulation is then communicated to neighboring atrial 
cardiomyocytes through gap junctions that allow passage of Ca2+ ions.  Propagation of 
electrical activation is interrupted at the AV node, allowing the ventricular chamber to fill 
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while the atrium contracts.  The electrical impulse is then conveyed through gap junctions 
from the AV node to the ventricular cells. 
Contraction initiates during the late stages of heart tube formation prior to 
looping, raising the possibility that all steps subsequent to this may be affected by this 
mechanical action.  Several studies have shown that abnormal heart function and 
defective cardiac morphogenesis are correlated (Rottbauer et al., 2001; Xu et al., 2002; 
Berdougo et al., 2003; Huang et al., 2003).  However, the intermediate steps and the 
signaling pathways involved are not well elucidated.   
Chamber (working) and nonchamber (nonworking) myocardium 
 The ability of the myocardial cells to contract in a coordinated and directed 
manner is a result of patterning in the heart tube that gives rise to specialized regions.  
These specialized regions can be grouped under the more general categories of chamber 
myocardium (atrium and ventricle) and nonchamber myocardium (sinus venosus (SV), 
AV canal and outflow tract).  Nonchamber myocardium retains most of the properties of 
the primitive heart tube, whereas chamber myocardium has undergone more elaborate 
differentiation to achieve mature form and function.  The chamber and nonchamber 
myocardium are delineated by a code controlled by the Tbx family (Hoogaars et al., 
2007).  Region-specific expression of tbx genes confers regional identity by activation of 
identity-promoting genes and repression of identity-opposing genes.   
 Localized expression of tbx2 at the AV canal confers identity to this region and 
represses expression of chamber-specific genes including atrial natriuretic factor (anf), 
chisel, and the gap junction genes connexin (cx) 40 and cx43 (Christoffels et al., 2004).  
Ectopic expression of tbx2 in chamber myocardium represses chamber-specific genes 
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(Christoffels et al., 2004).  Interaction with Nkx2.5 is required to repress anf (Habets et 
al., 2002).  Tbx3 is co-expressed with tbx2 at the AV canal and OFT, and is required for 
OFT alignment, ventricular septation, and repression of chamber-specific genes in the 
AV canal (Bakker et al., 2008; Mesbah et al., 2008).   Tbx5 is expressed in the atria and 
left ventricle, and maintains expression of anf and cx40 (Bruneau et al., 2001).  Tbx18 is 
expressed in SV and in a subset of SA node cells and ensures that these regions develop 
normally (Wiese et al., 2009).  In contrast to the restricted expression of the tbx members 
mentioned thus far, tbx20 is expressed throughout the developing heart.  Despite this 
expression pattern, it appears to act only in chamber myocardium where it activates 
expression of chamber-specific genes and represses tbx2 expression in ventricular 
myocardium (Cai et al., 2005; Singh et al., 2005; Stennard et al., 2005).  
 In addition to the transcriptional network controlled by the Tbx family, various 
signaling pathways have also been demonstrated to regulate patterning of the heart tube.  
Notably, BMP signaling has been implicated in regulating AV patterning, which requires 
AV-specific expression of bmp2 and bmp4 (Jiao et al., 2003; Ma et al., 2005).  Bmp2 is 
upstream of tbx2, activating its expression in the AVC (Ma et al., 2005; Park et al., 2006).  
It is not known whether bmp4 acts similarly.  Upstream of bmp2 and bmp4 is the Notch 
signaling pathway, acting through Hey2 proteins (Rutenberg et al., 2006).  Mouse mutant 
for hey2 have an expanded AV canal expression of bmp2.  Similarly, zebrafish mutant for 
hey2 (gridlock) have ectopic expression of bmp4 in the ventricle. 
 In conjunction with the molecular signatures that distinguish chamber from 
nonchamber myocardium, several structural and conduction differences arise in these two 
kinds of myocardium.  Chamber myocardium, through later processes of differentiation, 
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develop high gap-junction density, high conduction velocity, and pronounced 
trabeculation for ventricular myocardium (Rutenberg et al., 2006).  In contrast 
nonchamber myocardium resembles the primitive heart tube with regards to its strong 
auto-rhythmicity due to poor intercellular coupling.  The number and size of gap 
junctions is small, and Cx40 and Cx43 are rare or undetectable in nonchamber 
myocardium (Arguello et al., 1988; van Kempen et al., 1991; Fromaget et al., 1992; 
Gourdie et al., 1992; Gros et al., 1994).   Moreover, nonchamber myocardium contains 
loosely arranged myofibrils and sarcoplasmic reticulum in contrast to the highly ordered 
contractile apparatus in chamber myocardium. 
Summary of myocardial development 
The process of making a functional myocardium is meticulous.  It starts with the 
specification of the tissue lineage that will give rise to the contractile layer of the heart.  
What follows is a complicated progression of morphogenetic and differentiation events 
that will transform the bilateral set of precursor cells into a chambered, beating organ that 
propels oxygen- and nutrient-rich blood to circulate.  Fundamental to this transformation 
are the differentiation of specialized regions of the heart tube to chamber myocardium 
and the maintenance of characteristics of the primitive tube in nonchamber myocardium.  
Despite the complexity of these events, there are two underlying themes.  First, different 
events are orchestrated by the same signaling pathways that act differentially depending 
upon spatiotemporal control.    Second, members of one signaling family can act in 
concert with or against other members to regulate the same result.  In spite of advances in 
identifying these signaling pathways, elucidating how these pathways overlap and how 
they are integrated to result in the final output of a formed and functional heart remain a 
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challenge.  This dissertation will provide insights to these questions in the context of 
heparan sulfate proteoglycans (HSPGs), biomolecules important for cell signaling and 
communication.   
HSPGs 
 Developmental biologists first discovered the functional importance of HSPGs 
from genetic screens that isolated patterning defects in Drosophila and C. elegans 
(Herman and Horvitz, 1999; Bulik et al., 2000; Duncan et al., 2001; Filmus and Selleck, 
2001).  These studies corroborated what had already been gleaned of HSPG function 
from in vitro work.  More significant is that they have emphasized the importance of 
HSPGs in core developmental processes including setting up morphogen gradients and 
growth factor signaling.  This ability is a result of HSPG structure and its biosynthesis. 
HSPGs are composed of cell surface or extracellular matrix (ECM) core proteins 
that have attachment sites for glycosaminoglycan (GAG) chains.  The GAG chains in 
HSPGs are unbranched, charged polysaccharides composed of repeating disaccharide 
units of N-acetylglucosamine and glucuronic acid (Esko and Lindahl, 2001).  These sugar 
chains are further modified through N-deacetylation/N-sulfation, epimerization, and O-
sulfation.  Not all sugar residues are modified, resulting in GAG chains with relatively 
small clusters of modified units interspersed with larger sections of unmodified units 
(Esko and Selleck, 2002).  This results in an astounding level of structural heterogeneity, 
producing GAG chains with varying specificities for protein binding (Park et al., 2000).  
Most of the genes encoding the core proteins and the enzymes that synthesize and modify 
the GAG chains have been identified, and gene knockouts and knockdowns in various 
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animal models have elucidated their roles in development (Bulow and Hobert, 2006).  In 
contrast how biosynthesis is controlled and regulated remains poorly understood. 
Tissue-specific expression of the core proteins dictates spatiotemporal expression 
of GAG chains and the repertoire of modifying enzymes can also differ between cells 
(Park et al., 2000; Esko and Lindahl, 2001).  This, in theory, could impact how a cell 
interacts with a ligand, a neighboring cell, or the ECM.  The “glyco code” presented by 
these GAG chains is an essential level of regulation but is not well explored.  
This dissertation will address the importance of 3-O-sulfation, one type of O-
sulfation catalyzed by 3-O-sulfotransferases (3-OSTs), in zebrafish heart development.  
The biological function of this rare type of modification is poorly understood.  Knockout 
of the 3-OST-1 gene in mouse resulted in intrauterine growth retardation and lethality in 
certain genetic backgrounds (Shworak et al., 2002; HajMohammadi et al., 2003).  
Because the existence of other 3-OST genes may have compensated for the loss of 3-
OST-1, other phenotypes may have been masked.  The role of 3-O-sulfation has also 
been studied in invertebrates where knockdown of 3-OST-B in Drosophila resulted in 
neurological phenotypes (Kamimura et al., 2004).  Aside from these studies, no other in 
vivo function has been ascribed to 3-O-sulfation. 
That 3-O-sulfation could modulate heart development is a tantalizing concept yet 
not too surprising.  Given the functions that have been discovered for HSPGs in 
development, it is not far-fetched that this modification could add another level of 
regulation to the complex activities occurring during heart development.  It could 
potentially provide insight as to how the different signaling pathways acting to form the 
heart are integrated to achieve that ultimate goal. 
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3-OST-7 REGULATES MYOFIBRILLOGENESIS TO CONTROL 
HEART CONTRACTION IN ZEBRAFISH 
Abstract 
3-O-sulfation is a rare and specific modification of glycosaminoglycan chains on 
heparan sulfate proteoglycans catalyzed by a family of 3-O-sulfotransferases (3-OSTs).  
Despite gene expression studies suggesting distinct roles for different members of the 3-
OST family in embryonic development, we have limited understanding of in vivo 
functions of this type of modification.  In this study we demonstrate that 3-OST-7 
regulates cardiac development in zebrafish.  Morpholino knockdown of 3-OST-7 resulted 
in ventricular noncontraction, and was rescued by ubiquitous overexpression of 3-OST-7 
in transgenic zebrafish.  Cardiac precursor cells were specified correctly, and atrial and 
ventricular cardiomyocytes had normal action potentials and calcium transients, 
indicating the noncontractile ventricle undergoes normal excitation cycling.   In contrast, 
3-OST-7 morphants had aberrant sarcomere assembly, thus uncoupling contraction from 
excitation.  Moreover, transcription of a sarcomeric gene, tropomyosin4 (tpm4), was 
donwregulated in 3-OST-7 morphants.  Strikingly, overexpression of tpm4 was capable 
of rescuing ventricular noncontraction in 3-OST-7 morphants, indicating 3-OST-7 is 
required for transcription of tpm4, which then ensures functional levels of Tpm4 and 
other proteins in the sarcomere.  Together these results revealed 3-OST-7 as the first
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member of a novel pathway in cardiac development that regulates transcription of tpm4, 
and coordinates sarcomere assembly and ventricle function. 
Introduction 
Vertebrate heart development is a complex process.  It begins with events that 
specify the endocardial and myocardial lineages, which are then organized in a specific 
design to render it functional (Stainier, 2001; Glickman and Yelon, 2002).  After 
gastrulation, myocardial precursors are situated in bilateral positions in the anterior lateral 
plate mesoderm (LPM).  Through expression of genes encoding sarcomere proteins, such 
as cardiac myosin light chain 2 (cmlc2), these precursor cells initiate differentiation 
(Yelon et al., 1999).  While differentiation and morphogenetic events transform the 
bilateral set of precursors into the heart tube, the primitive heart also begins to function.  
A molecular framework has emerged that elucidates the commitment of exclusive 
lineages to discrete regions of the heart, and the underlying cellular decisions that direct 
the three-dimensional events of cardiac formation (Evans et al., 2010; Noseda et al., 
2011).  Despite these advances in our understanding of heart development, critical 
questions remain in the field and unknown players remain to be discovered.  In this study, 
we focus on the role of heparan sulfate proteoglycans (HSPGs) in heart development. 
HSPGs are cell surface and extracellular matrix molecules composed of a core 
protein to which glycosaminoglycan (GAG) chains are covalently linked.  Their location 
and the ability of HSPGs to interact with signaling ligands and receptors and extracellular 
matrix (ECM) components place them at a unique advantage to modulate complex 
biological processes such as morphogenesis, tissue repair and host defense (Park et al., 
2000; Hacker et al., 2005; Lamanna et al., 2007).   
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The specificity of interactions of an HSPG and its environment is due, in part, to 
the GAG chains (Lin, 2004; Bulow and Hobert, 2006; Lamanna et al., 2007).  The GAG 
chains in HSPGs are unbranched, charged polysaccharides composed of repeating 
disaccharide units of N-acetylglucosamine and glucuronic acid.  These chains are 
subjected to several kinds of modifications: N-deacetylation/N-sulfation, epimerization, 
and O-sulfation.  Not all sugar residues are modified, resulting in GAG chains with 
relatively small clusters of modified units interspersed between large sections of 
unmodified units (Esko and Selleck, 2002).  This gives rise to an astounding level of 
structural heterogeneity, producing GAG chains with varying specificities for protein 
binding (Park et al., 2000).  The repertoire of modifying enzymes differs between cells 
(Park et al., 2000), which in theory could impact how a cell interacts with a ligand, a 
neighboring cell, or the ECM.  Previous gene knockdown and knockout studies have 
already documented the roles of these modifying enzymes (Bulow and Hobert, 2006), but 
none has been implicated in heart development.   
 In this study, we focus on a rare and specific kind of O-sulfation, 3-O-sulfation, 
performed by a family of enzymes, the 3-O-sulfotransferases (3-OSTs).  3-OSTs catalyze 
transfer of a sulfate group to the hydroxyl of the third carbon of N-sulfated glucosamine 
residues (Esko and Selleck, 2002).  Previous work in our lab has identified and cloned the 
3-OST family in zebrafish (Cadwallader and Yost, 2006b).  Gene expression analysis 
reveals dynamic spatial and temporal expression patterns for the eight 3-OST family 
members suggesting distinct roles in the developing embryo.   
Here we show that morpholino knockdown of one of eight 3-OSTs in zebrafish, 
3-OST-7, gives a specific cardiac phenotype at 48 hours postfertilization (hpf).  3-OST-7 
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is expressed ubiquitously early in development (Cadwallader and Yost, 2006b), but 
morpholino knockdown results in a noncontracting ventricle.  Examining this 3-OST-7 
knockdown model demonstrates myofibrillogenesis is dependent on 3-OST-7 and that 
ventricular noncontraction occurs because of uncoupling of contraction from excitation 
due to aberrant sarcomeres.  Results show that the noncontractile ventricle in 3-OST-7 
morphant zebrafish can be rescued by overexpression of a sarcomeric protein, 
tropomyosin4 (Tpm4).  This indicates that 3-OST-7 is required for myofibrillogenesis, 
providing a novel mechanism for the regulation of cardiac cell physiology.   
Results 
Cardiac ventricle contraction requires 3-OST-7 
 To begin elucidating the role of 3-OST-7 in development, we injected two 
different antisense morpholinos (MO) to block protein expression.   Zebrafish embryos 
injected with either a translation-blocking (MO1) or a splice-blocking (MO2) MO had no 
perceived gross morphological difference from control embryos until 48 hpf, at which 
stage pericardial edema and blood pooling became obvious in 3-OST-7 morphants 
(Figure 2.1A and 2.1B).  These classic indications of a cardiovascular defect prompted a 
closer inspection of the heart.  Visualizing the heart using transgenic Tg(cmlc2:gfp) 
zebrafish (Huang et al., 2003) revealed that 3-OST-7 morphants have a hypoplastic 
cardiac ventricle that does not contract properly (Figure 2.1F and 2.1G, and Supplemental 
Movie 2.2), resulting in poor blood circulation (Figure 2.1H, Supplemental Movie 2.4).  
In contrast, a control embryo, had a clearly contractile ventricle, which undergoes 
sequential diastole (Figure 2.1C) and systole (Figure 2.1D).  The atrium of 3-OST-7 
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morphants, on the other hand, was contracting and looked similar to control (Figure 2.1C, 
2.1D, 2.1F, and 2.1G). 
 To test whether the noncontracting ventricle phenotype in 3-OST-7 morphants 
was specifically due to MO knockdown of 3-OST-7, we attempted to rescue the 
phenotype by injection of 3-OST-7 mRNA that does not bind MO.  This approach was 
not successful in rescuing the phenotype (data not shown), perhaps due to issues of 
mRNA or protein stability, prompting us to create stable transgenic zebrafish lines 
expressing 3-OST-7 ubiquitously or in a heart-specific manner.  Utilizing the Tol2kit 
cloning system (Kwan et al., 2007), we made transgenic zebrafish overexpressing 3-OST-
7 under the control of the !-actin promoter for ubiquitous expression (Tg(!-actin:3-OST-
7)) or the cmlc2 promoter for heart-specific expression (Tg(cmlc2:3-OST-7)).  The MO 
binding sequence is not present in either construct so that MO would not inhibit 
transgenic expression of 3-OST-7.  Both transgenes had a 3’ IRES-EGFP-polyA tag 
downstream of 3-OST-7 coding region, enabling identification of zebrafish 
overexpressing 3-OST-7 by co-expression of GFP.  We observed significant rescue of the 
noncontractile ventricle in transgenic Tg(!-actin:3-OST-7-IRES-EGFP) embryo (Figure 
2.1I), but not in Tg(cmlc2:3-OST-7-IRES-EGFP) (Figure 2.1J).  Rescue of the 
noncontracting ventricle phenotype by ubiquitous overexpression of 3-OST-7 in Tg(!-
actin:3-OST-7-IRES-EGFP) embryo demonstrates the noncontracting ventricle 
phenotype is specific to knockdown of 3-OST-7.  Moreover, rescue in Tg(!-actin:3-OST-
7-IRES-EGFP) embryo and not in Tg(cmlc2:3-OST-7-EGFP) embryo suggests either a 
spatial or a temporal requirement for 3-OST-7 beyond the expression driven by the cmlc2 







Figure 2.1.  3-OST-7 is required for ventricular contraction in the zebrafish heart.  Lateral 
views of control (uninjected, wild-type) (A) and 3-OST-7 morphant (B) embryos at 48 
hpf showing edema (red arrowhead) and blood pooling (black arrowhead) with 
knockdown of 3-OST-7.  Lateral views of hearts in control (C and D) and 3-OST-7 
morphants (injected with 3-OST-7 MO2) (F and G) Tg(cmlc2:gfp) embryos at periods of 
ventricular diastole (C and F) and systole (D and G).  Dorsal aorta in control (E) and 3-
OST-7 morphant (H) embryos show blood cells (red boxes) were not circulating normally 
in morphants.  (I) Injection of 3-OST-7 MO2 in Tg(!-actin:3-OST-7-IRES-EGFP) 
embryos rescued the noncontractile ventricle phenotype (P<0.039).  (J) Injection of same 
3-OST-7 MO did not rescue the phenotype in Tg(cmlc2:3-OST-7-IRES-EGFP) 
(P<0.601).  Graphs depict the percentage of embryos with phenotype in 3-OST-7-
overexpressing (GFP+, green bar) or non-3-OST-7-overexpressing (GFP-, white) 
embryos from individual crosses between one of three transgenic founders and wild-type 














Heart field is specified correctly in 3-OST-7 morphants 
 A fully formed and functional heart is generated by the precise coordination of 
patterning events and cell movements.  This complex process begins with the 
specification of cardiac cell precursors of myocardial and endocardial lineages, overall 
termed the heart field (Stainier, 2001; Glickman and Yelon, 2002).  To determine 
whether the noncontracting ventricle in 3-OST-7 morphants is a result of aberrant heart 
field specification, we used several techniques to visualize the heart field to assess 
whether it is correctly specified in 3-OST-7 morphants.  First we performed in situ 
hybridizations using markers for the cardiac precursor cells and the anterior LPM, tissue 
from which these cells arise.  Combinatorial expression of the transcription factors hand2 
and nkx2.5 serves as a marker for cardiac precursor cells (Schoenebeck et al., 2007).   
Expression of the LPM marker, hand2, in 3-OST-7 morphants was comparable to 
uninjected zebrafish (Figure 2.2A and 2.2B) and indicated that the anterior LPM was 
unaltered in 3-OST-7 morphants.  Similarly nkx2.5 was unaltered in 3-OST-7 morphants 
(Figure 2.2C and 2.2D).  Furthermore a marker for myocardial precursors, cmlc2, was 
also expressed normally in 3-OST-7 morphants (Figure 2.2E and 2.2F).  Next we used 
transgenic Tg(fli1:EGFP) embryos (Lawson and Weinstein, 2002) to examine the 
endocardial precursor cells and found that these cells were patterned similarly in control 
embryos and 3-OST-7 morphants (Figure 2.2G and 2.2H).  In situ hybridizations for 
amhc (Figure 2.2I and 2.2J) and vmhc (Figure 2.2K and 2.2L), markers for myocardial 
precursors of the atrial and ventricular lineages, respectively, also indicated atrial and 










Figure 2.2.  Heart field specification proceeds normally in 3-OST-7 morphants.  Dorsal 
views (anterior on top) of control (uninjected, wild-type) (A, C, E and K), control MO 
(injected with control 3-OST-3Z MO) (G and I) and 3-OST-7 morphant (B, D, F, H, J 
and L) embryos; n=35 for each group.  In situ hybridizations for: lateral plate mesoderm 
marker hand2 (A and B, 17 hpf) and cardiac precursor cell marker nkx2.5 (C and D, 17 
hpf), myocardial precursor cell marker cmlc2 (E and F, 17 hpf), atrial precursor cell 
marker amhc (I and J, 20 hpf), and ventricular precursor cell marker vmhc (K and L, 18 
hpf) showing comparable levels and patterns of expression in control and 3-OST-7 
morphant embryos.  Imaging of fli1 expression in Tg(fli1:EGFP) zebrafish at 18 hpf 




















demonstrate heart field specification proceeds normally in 3-OST-7 morphants and is not 
likely the cause for the noncontracting ventricle.  
Noncontracting ventricle in 3-OST-7 morphants 
 generates action potentials  
A fully functional heart characteristically undergoes excitation-contraction 
coupling process, a physiological process whereby an electrical stimulus (action 
potential) is converted to a mechanical response (contraction) (Stern, 1992).  To 
determine whether the noncontracting ventricle in 3-OST-7 morphants results from 
uncoupling of contraction from excitation, we assessed whether the morphant ventricle 
could generate action potentials and calcium transients.  To record action potentials, we 
performed patch clamp analysis on either the atrium or ventricle of hearts that were 
explanted from zebrafish embryos at 48 hpf (Figure 2.3A and 2.3B).  As expected, atria 
of 3-OST-7 morphants were able to generate action potentials comparable to atria of 
control embryos (Figure 2.3C and 2.3D).  Surprisingly, however, action potentials were 
also recorded for the noncontracting ventricles of 3-OST-7 morphants and these action 
potentials were similar to those recorded for ventricles of control embryos (Figure 2.3E 
and 2.3F).  Moreover, analysis of action potential parameters revealed that there were no 
statistically significant differences between control embryos and 3-OST-7 morphants 
(data not shown).  This demonstrates the ability of 3-OST-7 morphant ventricles to be 
electrically stimulated to generate action potentials.  Specifically this indicates ion 












Figure 2.3.  Noncontracting ventricle in 3-OST-7 morphants generates normal action 
potentials.  (A) Zebrafish embryos were injected with 5.4 ng of 3-OST-7 MO1 at one-cell 
stage and allowed to develop until 48 hpf.  The heart was then dissected out of the 
embryo and placed in a recording chamber perfused with solution containing 140 mM 
NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM Hepes (pH 
7.4).  (B) A suction pipette was used to patch clamp the heart at the atrial or ventricular 
region.  Action potentials were recorded from atria (C and D) and ventricles (E and F) of 
control (uninjected, WT) (C and E) and 3-OST-7 morphant (D and F) embryos.  The 
action potentials were comparable between control and 3-OST-7 morphant embryos.  
















Noncontracting ventricle in 3-OST-7 morphants  
generates calcium transients 
Once a myocardial cell has been stimulated by action potentials, this electrical 
signal is transduced intracellularly by the release of calcium ions from the sarcoplasmic 
reticulum (Bers, 2002).  To assess whether this release occurs in 3-OST-7 morphant 
ventricles, we used two different techniques to image the calcium waves that occur  
during this process.  In the first technique, we explanted hearts of zebrafish embryos and 
bathed them in the calcium indicator Fluo-4.  These were then imaged by confocal 
microscopy and cardiac regions were selected to record the calcium transients and 
measure amplitude and time of decay.  Comparable calcium waves were detected in 
hearts of both control embryos and 3-OST-7 morphants (Supplemental Movies 2.5 and 
2.6). The 3-OST-7 morphant ventricles generated calcium transients similar to those 
generated by ventricles from control embryos (Figure 2.4C and 2.4D).  There were no 
significant differences in the calcium transient amplitude and calcium transient decay 
between ventricles of 3-OST-7 morphant embryos and ventricles of control embryos 
(Figure 2.4E and 2.4F).   
In the second technique, 3-OST-7 MO or control MO was injected into transgenic 
Tg(cmlc2:gCaMP)s878 embryos (Chi et al., 2008) that allowed for live calcium imaging in 
intact zebrafish.  Similar to the other technique, calcium waves were detected in 3-OST-7 
morphant hearts (Supplemental Movies 2.7 and 2.8) and comparable optical maps were 
generated for both control embryos and 3-OST-7 morphants (Figure 2.4G and 2.4H).  







Figure 2.4.  Noncontracting ventricle in 3-OST-7 morphants generates calcium transients. 
Zebrafish was injected with 3-OST-7 MO1 or control 3-OST-5 MO at one-cell stage and 
allowed to develop until 48 hpf.  The heart was then dissected out of the embryo, 
incubated in Fluo-4, and imaged using a confocal microscope.  Regions were selected 
from atrium and ventricle to record the calcium transients (A-D) and measure the Ca2+ 
transient amplitude (E) and Ca2+ transient decay (F).  No significant difference was 
detected between control and 3-OST-7 morphant embryos (P<0.30 for atrial transient 
amplitude; P<0.16 for ventricular transient amplitude; P<0.37 for atrial transient decay; 
and P<0.51 for ventricular transient decay).  Using a different technique to image the 
calcium transients, 3-OST-7 MO1 or control 3-OST-3Z MO was injected into 
Tg(cmlc2:gCaMP)s878 embryos at one-cell stage and allowed to develop until 48 hpf.  
Optical maps of calcium activation for a single cycle, represented by isochronal lines 
every 20 ms, show calcium activation and conduction velocity proceed normally in 3-
OST-7 morphants (H) compared to control MO injected embryos (G).  Conduction 
proceeds from the atrium through the atrioventricular (AV) canal to the ventricle and 
numbers indicate the temporal sequence of calcium activation.  Color bar chart 











Together these results demonstrated the ability of the noncontracting ventricle of 
3-OST-7 morphants to release calcium from the sarcoplasmic reticulum and to re-uptake 
it at the end of the cycle.  Particularly this indicates ryanodine receptors that are 
important in calcium cycling are functional in 3-OST-7 morphants.  In addition, the 
calcium waves that were visualized by these imaging techniques (Supplemental Movies 
2.5 through 2.8) indicated that the gap junctions that allow normal conduction to occur 
were also intact. 
3-OST-7 is required for myofibrillogenesis and sarcomere assembly 
The previous observations that action potentials and calcium transients were 
normally generated in 3-OST-7 morphants that had noncontracting ventricles illustrated 
the uncoupling of contraction from excitation.  Moreover, this indicates defective 
contraction in 3-OST-7 morphants might be due to defects in the myocardial contractile 
apparatus, which is the direct target of calcium ions released from the sarcoplasmic 
reticulum during electrical excitation of the heart.  To determine whether noncontraction 
of 3-OST-7 morphant ventricle is due to aberrant sarcomeres, we used 
immunohistochemistry to visualize proteins comprising the sarcomeric structure of the 
heart.  Using MF20 and phalloidin to stain sarcomeric myosin and the actin filaments, 
respectively, we found that these filaments were disorganized in 3-OST-7 morphant 
hearts (Figure 2.5B and 2.5D) compared to the orderly arrays in hearts of control 
embryos (Figure 2.5A and 2.5C).  Only ventricular myosin appeared to be disrupted; 
myosin filaments appeared to be normally organized in the atrium of 3-OST-7 morphants 
(Figure 2.5B).  Furthermore, atrial myosin stained by S46 antibody was normal in both 









Figure 2.5.  Knockdown of 3-OST-7 disrupts sarcomere organization.  Whole mount 
immunohistochemistry (IHC) was performed on fixed 48 hpf control (injected with 
control 3-OST-3Z MO) or 3-OST-7 morphant embryos to detect cardiac sarcomere 
proteins (n=30 for each group).  The heart was then dissected out of the embryo, mounted 
on cover slips and imaged using a confocal microscope (thus, the dorso-ventral 
orientation of the mounted hearts was random).  IHC using anti-myosin (MF20) and 
phalloidin revealed myosin and actin filaments were disorganized in ventricles of 3-OST-
7 morphants (B and D) compared with control (A and C).  IHC using anti-cardiac 
troponin T (Tnnt2) antibody and anti-tropomyosin (Tpm) antibody revealed levels of 
these proteins are greatly reduced in 3-OST-7 morphants  (F and H) compared to control 














tropomyosin were also noticeably decreased in 3-OST-7 morphant hearts (Figure 2.5F 
and 2.5H) compared to control embryo hearts (Figure 2.5E and 2.5G).  Together these 
results suggest the noncontraction of the ventricle in 3-OST-7 morphants is correlated 
with reduced levels and disorganization of sarcomere proteins. 
3-OST-7 regulates transcription of tpm4 
Strikingly, cardiac troponin T (tnnt2) and tropomyosin4 (tpm4) zebrafish mutants 
(Sehnert et al., 2002; Zhao et al., 2008) share similar phenotypes with the 3-OST-7  
morphants.  Both these mutants and 3-OST-7 morphants have noncontractile hearts and 
disorganized sarcomeres.  Since it appears that 3-OST-7 regulates cardiac troponin T 
(Tnnt2) and tropomyosin (Tpm) protein levels (Figure 2.5F and 2.5H), we next addressed 
whether this regulation occurs at the transcriptional level for either of these sarcomeric 
genes.  In situ analysis for tnnt2 expression at 20 hpf, 24 hpf, and 48 hpf in morphants 
(Figure 2.6B, 2.6F, and 2.6J) revealed that tnnt2 transcript levels were similar to control 
(Figure 2.6A, 2.6E, and 2.6I).  In contrast transcript levels of tpm4, were reduced in 3-
OST-7 morphants (Figure 2.6D, 2.6H, and 2.6L) compared to control embryos (Figure 
2.6C, 2.6G, and 2.6K).  Interestingly, we also found that tpm4 mRNA levels were 
downregulated in 3-OST-7 morphant hearts in a microarray analysis comparing wild-type 
and 3-OST-7 morphant hearts at 48 hpf (data not shown).   
Tpm4 is required for 3-OST-7 dependent ventricular contraction  
The previous experiments demonstrated that 3-OST-7 is necessary for 
transcription of tpm4, which then ensures there would be normal levels of Tpm4 and 
presumably other sarcomeric proteins as well, such as Tnnt2.  We next wanted to 










Figure 2.6.  3-OST-7 controls expression of tpm4.  In situ analysis for tnnt2 showed 
comparable transcript levels and patterns of expression for 3-OST-7 morphants (B, F, and 
J) and control (injected with control 3-OST-5 MO) embryos (A, E, and I) at 20 hpf (A 
and B), 24 hpf (E and F), and 48 hpf (I and J).  In contrast tpm4 transcripts were 
decreased in 3-OST-7 morphants (D, H, and L) compared to control embryos (C, G, and 
K) at 20 hpf (C and D) and 24 hpf (G and H).  Reduction is especially pronounced at 48 
hpf (K and L).  A through D are dorsal views with anterior on top; E to L are ventral 






















contraction.  To examine this, we overexpressed tpm4 by injection of tpm4 RNA.  
Overexpression of tpm4 RNA in control embryos had no perceived gross morphological 
effect, nor did it alter cardiac function (Figure 2.7).  Strikingly, overexpression of tpm4 
RNA in 3-OST-7 morphants rescued ventricular noncontraction (Figure 2.7), 
demonstrating that tpm4 is required for regulation of ventricular contraction by 3-OST-7. 
Discussion 
The significance of heparan sulfate proteoglycans (HSPGs) in developmental 
biology came about from genetic screens in invertebrates aimed at isolating patterning 
defects (Herman and Horvitz, 1999; Bulik et al., 2000; Duncan et al., 2001; Filmus and 
Selleck, 2001).  Since then, most of the genes coding for the HSPG core proteins and the 
biosynthetic enzymes that build and modify the GAG chains have been identified 
(Cadwallader and Yost, 2006a, b, 2007).  Strikingly, the GAG-chain modifying enzymes 
are encoded by multiple family members, but very few have been assayed for function.   
In this study we demonstrate that one of the enzymes that places a rare 3-O-
sulfation on the GAG chains, 3-OST-7, has a novel and highly specific function in 
cardiac development.  In 3-OST-7 knockdown zebrafish, early cardiac cell specification, 
patterning, and cardiac tube looping are relatively normal, and atrium contraction is 
normal.  In contrast, ventricle contraction is aberrant.  By several methods, this 
ventricular noncontraction does not appear to be due to cellular electrophysiological 
defects.  Strikingly, 3-OST-7 is required for the transcription and accumulation of tpm4 
mRNA in the ventricle, which then ensures that normal levels of Tpm4 protein are 
present.  Tpm4 appears to be a lynchpin in sarcomere assembly and stabilization, because 












Figure 2.7. Overexpression of tpm4 rescues the noncontracting ventricle phenotype in 3-
OST-7 morphant embryos.  Overexpression of tpm4 in control embryos did not alter 
cardiac function.  Strikingly, overexpression in 3-OST-7 morphants rescued ventricular 



























sarcomeric proteins, rescues sarcomere structure, and rescues the ventricular contraction 
defect in 3-OST-7 morphants (Figure 2.8).   Thus, knockdown of 3-OST-7 uncouples 
contraction from the normally functioning excitation cycle by perturbing tpm4  
transcription, leading to defective myofibrillogenesis.  This places the 3-OST-7-
dependent 3-O-sulfation of extracellular GAG chains as the first member of an otherwise 
unknown signaling pathway that is upstream of tpm4 transcription and coordinated 
sarcomere assembly (Figure 2.8).   
What is striking about the knockdown of 3-OST-7 is that the phenotype is only 
50-60% penetrant, raising the possibility that another member of the 3-OST family can 
partially compensate for reduction of 3-OST-7.  We have explored this possibility by 
knocking down several other members of the 3-OST family, and found that only one 
other member, 3-OST-1, the closest relative of 3-OST-7, has a similar cardiac phenotype 
as knockdown of 3-OST-7, with similar penetrance (data not shown).  Furthermore, 
double knockdown of 3-OST-7 and 3-OST-1 increased penetrance of the cardiac 
ventricular phenotype (data not shown), arguing that these two 3-OSTs are partially 
functionally redundant.  However, knockdown of 3-OST-1 has a more severe effect on 
the heart, including defects in atrial contraction as well.    
Another intriguing aspect of the 3-OST-7 knockdown is the organ-specific 
phenotype, despite ubiquitous 3-OST-7 expression in early development (Cadwallader 
and Yost, 2006b). The cardiac ventricular contraction defect in 3-OST-7 morphants could 
be rescued by ubiquitous transgenic expression of 3-OST-7 protein (with a modified 
construct that could not bind morpholino), indicating that the cardiac contraction 











Figure 2.8. Model for role of 3-O-sulfation catalyzed by 3-OST-7 in cardiac 
development.  Under normal conditions, specific 3-O-sulfation patterns interact with 
unidentified molecule and activate a signaling pathway that turns on transcription of 
tpm4.  Tpm4 then stabilizes the sarcomere and ensures proper contraction.  Knocking 
down 3-OST-7 results in loss of 3-O-sulfation and reduced levels of tpm4 transcripts and 


































contrast, it is curious that the cardiac phenotype is not rescued by a cmlc2-driven 
transgene that expresses just in cardiomyocytes. While it is possible that 3-OST-7 
expression is required in some other neighboring tissue, and not in cmlc2-positive 
cardiomyocytes (thus, Figure 2.8 proposes a cell-cell communication to regulate tmp4 
transcription), we cannot exclude the possibility that 3-OST-7 is also required in 
cardiomyocytes but that the timing or strength of cmlc2 transgene expression is 
insufficient to rescue the knockdown. Nonetheless, ubiquitous expression of tpm4, by 
mRNA injection into one-cell embryos, does not by itself alter cardiac function, but is 
able to rescue the 3-OST-7 knockdown cardiac contraction phenotype.  
We propose that 3-OST-7-dependent 3-O-sulfation of GAG chains on cell surface 
or extracellular HSPGs is required for activation of an unknown cell-cell signaling 
pathway that regulates transcription of a lynchpin sarcomere protein, Tpm4 (Figure 2.8).  
Other components that are upstream of Tpm4 regulation are unknown. It is possible that 
the Notch pathway participates, since sulfation by 3-OST-B, one of two 3-OSTs in 
Drosophila, is implicated to interact with the Notch signaling pathway (Kamimura et al., 
2004).  However, known Notch mutants (Holley et al., 2000) or pharmacological 
inhibition of the Notch pathway do not have ventricular contraction defects similar to 3-
OST-7 knockdown (data not shown).  Another pathway, FGF signaling, was considered 
because FGF signaling has been shown to be dependent on HSPGs for receptor-ligand 
complex formation in vitro (Yayon et al., 1991; Pellegrini et al., 2000; Schlessinger et al., 
2000; Lin, 2004).  However, known FGF pathway mutants (Reifers et al., 2000; Marques 
and Yelon, 2009) or morphants (Neugebauer et al., 2009) have not been reported to have 
specific ventricular contraction defects, and pharmacological inhibition does not result in 
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similar defects (Neugebauer et al., 2009). It is possible that the 3-OST-7 specific GAG 
modification is required to modulate the convergence of multiple signaling pathways to 
regulate transcription of tpm4, sarcomere assembly and ventricular contraction.  
Zebrafish is an outstanding model organism to study the coordination of 
embryonic cardiac morphogenesis with physiological function.  Our study demonstrates 
that 3-OST-7 is required for normal heart function, but is dispensable for specification of 
cardiac lineages and early formation of the heart.  We anticipate that further investigation 
of this 3-OST-7 knockdown model will greatly improve our understanding of how 
specific modifications of HSPGs shape heart development and cardiac function.  
Exploring the effects of noncontraction on later steps of cardiac morphogenesis will also 
be instructive in assessing feedback loops between function and structure.  Ultimately, 
defining the pathway that transmits the 3-OST-7-dependent sulfation signal to its 
demonstrated role in cardiac function will offer major insights as to how extracellular 
information is relayed to cellular behavior. 
Materials and methods 
Zebrafish strains and lines 
Zebrafish were maintained under standard laboratory conditions at 28.5°C.  In 
addition to Oregon AB wild-type, the following transgenic lines were used: 
Tg(cmlc2:GFP)(Huang et al., 2003), Tg(fli1:EGFP) (Lawson and Weinstein, 2002), 
Tg(cmcl2:gCaMP)s878 (Chi et al., 2008). 
Morpholino and RNA injection 
The following morpholino oligonucleotides and their corresponding 
concentrations were used: 3-OST-7 MO1 (translation-blocking MO with sequence 5’-
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CACATAACTCAGAAGATTGGCCATG-3’, 5.4 ng) and 3-OST-7 MO2 (splice-
blocking MO with sequence 5’- CACATCTGGAAGACACAAGAGAGAG-3’, 1.4 ng) 
to knockdown 3-OST-7; 3-OST-5 MO (5’-GTCCAGTCAGGTCAAGGGCAGCTCA-3’, 
2.7 ng) and 3-OST-3Z MO (5’-GTCCAGTCAGGTCAAGGGCAGCTCA-3’, 5.4 ng), 
which targeted other 3-OSTs, as control.  Embryos were injected at the 1-2 cell stage.  
Transgenesis and rescue 
The Tol2kit cloning system (Kwan et al., 2007) was used to generate Tg(cmlc2:3-
OST-7-IRES-EGFP) and Tg(!-actin:3-OST-7-IRES-EGFP).  The middle entry vector 
encoding 3-OST-7 was generated using the pCS2-3-OST-7 expression vector as a source 
construct.   It does not contain 3-OST-7 MO2 binding sequence so that 3-OST-7 MO2 
would not inhibit transgenic expression of 3-OST-7.  Multisite recombination reactions 
were performed as previously described (Kwan et al., 2007).  Transposase RNA was 
synthesized using mMessage mMachine kit (Ambion).  25 pg of transposase RNA and 30 
pg of cmlc2:3-OST-7-IRES-EGFP or 30 pg of !-actin:3-OST-7-IRES-EGFP plasmid 
DNA were injected into wild-type AB fish at the one-cell stage.  Potential transgenic 
founders (F0) were identified by scoring for GFP expression in hearts (cmlc2:3-OST-7-
IRES-EGFP) or ubiquitous GFP expression (!-actin:3-OST-7-IRES-EGFP).  Potential 
F0s were then crossed to wild-type AB fish to check for GFP expression.  Those that gave 
GFP-positive transgenic embryos were subsequently used for rescue experiments where 
1.4 ng of 3-OST-7 MO2 was injected into embryos from F0 x AB matings.  At 48 hpf, 
embryos were sorted by GFP fluorescence, then scored for ventricular noncontraction. 
tpm4 RNA was synthesized using the mMessage mMachine kit (Ambion) from 
the linearized pXT7-tpm4-tv1 expression vector.  The vector was a generous gift from 
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Anming Meng (Zhao et al., 2008).  175 pg of RNA was co-injected with 5.4 ng of 3-
OST-7 MO1 at the one-cell stage. 
In situ hybridization 
 Digoxigenin-labeled antisense riboprobes were synthesized using Digoxigenin 
RNA Labeling Kit (Roche).  cDNA plasmids encoding hand2, nkx2.5, cmlc2, amhc (a 
gift from Priya Choudhry), vmhc, tnnt2, and tpm4 (a gift from Anming Meng) were used.  
In situ hybridizations were performed as previously described (Essner et al., 2000), with 
anti-digoxigenin antibody incubation carried out using a Biolane HTI machine.  Embryos 
were cleared in 70% glycerol and photographed with a Nikon SMZ1000 camera.  Digital 
images were processed with Adobe Photoshop CS4.  
Action potential recordings 
Forty-eight hpf larvae were dechorionated and anesthetized with 0.02% tricaine 
for 1 to 2 minutes.  The heart was dissected from the thorax en bloc by using fine forceps 
and transferred to the recording chamber.  Only spontaneously beating whole hearts were 
studied.  All experiments were performed at 22oC to 24oC.  The recording chamber was 
perfused with external control solution containing (in mmol/L) NaCl 140, KCl 4, CaCl2 
1.8, MgCl2 1, glucose 10, and HEPES 10 (pH 7.4).  Suction pipettes were made from 
borosilicate capillary tubes and fire-polished to obtain resistances of 6-9 M! when filled 
with solution containing (in mmol/L) KCl 120, EGTA 5, K2ATP 5, MgCl2 5, and HEPES 
10 (pH 7.2).  The pipette was positioned adjacent to the heart and a seal was formed by 
application of minimal suction.  Using this technique, stable spontaneous APs were 
recordable for up to 3 hours. 
 54 
Calcium transient recordings and optical mapping 
 Two methods were used to observe calcium transients.  In the first method, Ca2+ 
transients were recorded in spontaneously beating explanted hearts at 48 hpf using fluo-4 
(Molecular Probes) loading and high-speed confocal scanning. Hearts were first incubated 
in the external control solution containing 10 !M fluo 4-AM and 0.35 mM probenicid at 
25°C for 2 min. Probenicid was included to help retard fluo-4 loss from the cells. The 
heart was then continuously bathed in the external control solution containing probenicid. 
High speed scanning at 63 frames/sec was achieved with a confocal microscope (Zeiss 5-
Live, excitation 489 nm, emission LP 505, 40x oil). Fluorescent signals (F) were 
normalized to baseline values (Fo).  The maximum Ca2+ transient amplitude (FMax/ Fo) was 
determined by averaging the peak amplitude of three consecutive transient signals.  The 
decay of the calcium transient was determined by a monoexponential fit of the decaying 
signal and averaging value of three consecutive transient signals.  
The other method utilized optical mapping in 3-OST-7 MO-injected and control 
MO-injected transgenic Tg(cmlc2:gCaMP)s878 embryos as previously described (Chi et 
al., 2008). 
Immunohistochemistry 
Immunohistochemistry using the primary antibodies MF20 (Developmental 
Studies Hybridoma Bank, 1:10), CT3 (Developmental Studies Hybridoma Bank, 1:10) 
and CH1 (Developmental Studies Hybridoma Bank, 1:10) was performed as described 
previously (Neugebauer et al., 2009).  Secondary antibody, either donkey anti-mouse 
Alexa Fluor 488 (Molecular Probes) or goat anti-mouse Alexa Fluor 488 (Molecular 
Probes), was used in 1:100 dilution.  Images were acquired using an Olympus Fluoview 
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FV300 laser scanning confocal microscope.  Digital images were processed with Adobe 
Photoshop CS4. 
Statistics 
 For rescue experiments in Tg(!-actin:3-OST-7-IRES-EGFP) or Tg(!-actin:3-
OST-7-IRES-EGFP), two-way ANOVA was performed using GraphPad Prism (version 
5.00 for Mac GraphPad Software).  For calcium transient amplitude and decay 
measurements, and tpm4 RNA rescue experiments, Student’s t-test was performed. 
Supplemental movies 
Movie 2.1. Movie shows lateral view of beating heart in control (uninjected, wild-type) 
Tg(cmlc2:gfp) embryo at 48 hpf.  Ventricle is left, atrium is right. 
Movie 2.2. Movie shows lateral view of impaired ventricular contraction in 3-OST-7 
morphant Tg(cmlc2:gfp) embryo at 48 hpf.  Ventricle is left, atrium is right. 
Movie 2.3.  Movie shows normal circulation in the trunk of control (uninjected, wild-type 
embryo. 
Movie 2.4.  Movie shows poor circulation in the trunk of 3-OST-7 morphant embryo.  
Movie 2.5.  Movie shows calcium waves in explanted heart stained with Fluo-4 of control 
(injected with control 3-OST-5 MO) embryo.  Ventricle is right, atrium is left.  
Movie 2.6.  Movie shows calcium waves in explanted heart stained with Fluo-4 of 3-
OST-7 morphant embryo. Ventricle is right, atrium is left. 
Movie 2.7.  Movie shows calcium activation and progression of conduction in control 
(injected with control 3-OST-3Z MO) Tg(cmlc2:gCaMP)s878 embryo.  Atrium is on top. 
Movie 2.8.  Movie shows calcium activation and progression of conduction in 3-OST-7 
morphant Tg(cmlc2:gCaMP)s878 embryo.  Atrium is slightly out of focus on top. 
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3-OST-7 REGULATES A FEEDBACK LOOP BETWEEN BMP  
SIGNALING AND CARDIOMYOCYTE CONTRACTION 
Abstract 
Cardiac function and circulation begin long before heart development is 
completed, making the heart an excellent system for studying the interrelationship 
between structure and function in development.  In this study, we utilized the 3-OST-7 
knockdown in zebrafish, which causes ventricular noncontraction, to demonstrate that 
contraction affects specific aspects of cardiac maturation, including the transition from an 
isometric cell shape to an elongated cell shape, and a feedback loop between bmp4 
expression and contractility.  3-OST-7 morphants had ectopic expression of bmp4 in the 
ventricle, which also occurred in two distinct contraction defect models, knockdown of 
the potassium voltage-gated channel gene kcnh2 (affected in Romano-Ward syndrome 
and long-QT syndrome) or knockdown of tnnt2 (tropomyosin-binding cardiac troponin T 
type 2, affected in human cardiomyopathies).  These results reveal a correlation between 
noncontraction and ectopic bmp4 expression.  Strikingly, cardiac contraction was rescued 
in 3-OST-7 morphants by the bmp4st72 mutation, demonstrating that a feedback loop 
controlled by 3-OST-7 exists between myocardial contraction and bmp4 
expression.  Together, these findings illustrate an intriguing interrelationship between 
cardiac structure and function that is modulated by 3-OST-7 and BMP4.
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Introduction 
 Vertebrate heart development requires an accurate integration of patterning and 
morphogenetic events leading eventually to the formation of a fully functional heart.  It 
initiates with the specification of the different tissue lineages that will compose the 
mature heart, followed by an intricate set of differentiation events that will transform the 
early heart field into a mature, beating organ.  This transformation is defined by the 
subspecialization of regions of the primitive heart tube to acquire characteristics of 
chamber myocardium or maintenance of some characteristics of the tube in nonchamber 
myocardium.  These complex events are orchestrated by a network of signals and 
transcription factors that could act differentially depending upon specific spatiotemporal 
cues.  Among the important players are major signaling pathways such as BMP signaling 
and Wnt signaling, which set the early stages of differentiation (Shi et al., 2000; Walters 
et al., 2001; Yang et al., 2006; Mandel et al., 2010), and the T-box (Tbx) family of 
transcription factors that confer chamber or nonchamber identity to the primitive heart 
tube (Hoogaars et al., 2007).  
 Ultimately, generation of a beating heart is the goal of these processes.  For the 
heart to contract, contractile proteins must be produced and assembled in units called 
sarcomeres and their contraction must be coupled to the electrical activation of the heart.  
The heart starts beating during the late stages of heart tube formation, and through its 
mechanical action, affects subsequent differentiation steps as shown in studies correlating 
defective morphogenesis with abnormal function (Rottbauer et al., 2001; Xu et al., 2002; 
Berdougo et al., 2003; Huang et al., 2003).  This makes the heart an excellent model 
system to study the relationship between form and function and to elucidate the 
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intermediate steps and signaling pathways involved.  In this study, we used the 3-O-
sulfotransferase-7 (3-OST-7) morpholino (MO) knockdown model in zebrafish, in which 
contraction of the ventricle is uncoupled from excitation due to defects in 
myofibrillogenesis. 
3-OST-7 is a member of a family of enzymes responsible for 3-O-sulfation in 
zebrafish.  This type of modification is associated with the glycosaminoglycan (GAG) 
chains present on heparan sulfate proteoglycans (HSPGs), biologically important 
molecules whose functions are due, in part, to these GAG chains (Esko and Selleck, 
2002).  The location of HSPGs, on the cell surface or in the extracellular matrix, and their 
structural heterogeneity place them at a unique advantage to influence signaling pathways 
and cell-cell or cell-matrix interactions (Esko and Lindahl, 2001).  This versatility has 
been demonstrated in various animal models where genes involved in biosynthesis and 
modification of HSPGs have been knocked out or knocked down (Bulow and Hobert, 
2006).   
Knocking down 3-OST-7 in zebrafish through the use of MO resulted in a 
noncontracting ventricle phenotype, which can be rescued by ubiquitous overexpression 
of 3-OST-7 in a transgenic (Tg(!-actin:3-OST-7)) zebrafish embryo.  We have also 
previously demonstrated that 3-OST-7 regulates transcription of a sarcomere gene, tpm4, 
and shown that the noncontracting ventricle phenotype can be rescued by overexpression 
of tpm4 RNA.  In this study, we examine the relationship between contraction and 





3-OST-7 is required for normal ventricular 
 cardiomyocyte morphology 
Marker analysis and visualization of the heart tube indicate early processes 
involved in heart development including heart field specification, cardiac fusion, and 
heart tube formation were normal (data not shown).  This would also argue that the 3-
OST-7 morphant ventricle achieved an early stage of differentiation, but then retained the 
characteristics of the primitive heart tube and did not proceed to further mature. We 
wanted to determine whether morphological aspects of differentiation were aberrant in 3-
OST-7 morphant ventricles. 
Normally, ventricular precursors have an isometric cell shape at 24 hours 
postfertilization (hpf), which becomes elongated at 48 hpf (Auman et al., 2007).  To 
determine whether this change in cell morphology occurs in 3-OST-7 morphants we 
performed whole-mount immunohistochemistry (IHC) to fluorescently label the cell 
membrane and compare cell areas using morphometric analysis.  We used anti-!-catenin 
antibody to outline the cells (Figure 3.1A and 3.1D) of 48 hpf Tg(cmlc2-DsRed-nuc) 
embryos (Mably et al., 2003).  This transgenic line ensured we were comparing 
myocardial cells (Figure 3.1B and 3.1E).  We observed that ventricular cells in control 
embryos had elongated morphologies (Figure 3.1A and 3.1C).  In contrast 3-OST-7 
morphant ventricular cardiomyocytes retained an isometric morphology at 48 hpf (Figure 
3.1D and 3.1F).  Using morphometric analysis to quantitate the observed morphological 






Figure 3.1.  Ventricular cardiomyocytes in 3-OST-7 morphants fail to transition from 
isometric to elongated cell shape.  Whole mount immunohistochemistry (IHC) was 
performed on fixed 48 hpf control embryos (injected with control 3-OST-3Z MO) and 3-
OST-7 morphants to compare cell morphologies and areas in Tg(cmlc2-DsRed-nuc) 
zebrafish (Mably et al., 2003).  IHC using anti-!-catenin (A and D) and anti-DsRed (B 
and E, cmlc2-nuc stands for nuclear expression of cmlc2-DsRed) allowed for delineation 
of cardiac cell membranes (red dotted outlines) and measurement of their areas.  C and F 
are merged images of anti-!-catenin (green) and DsRed (red) staining.  (G) Graph 
showing comparison of cell surface area (µm2) measurements for control and 3-OST-7 
morphants.  Surface area of ventricular cardiomyocytes in 3-OST-7 morphants was 
significantly smaller compared to control (P<1.0x10-4) (H) Graph showing comparison of 
circularity measurements for control and 3-OST-7 morphants.  A value of 1 corresponds 
to a perfect circle.  Ventricular cardiomyocytes in 3-OST-7 morphants were significantly 
rounder than those in control (P<4.0x10-3).  For the surface area and circularity 
measurements, five cells were chosen from each of 10 embryos in each injection group, 
and cell tracings, surface area measurements, and shape assessments were done using 



















ventricular cardiomyocyte surface area was significantly smaller in 3-OST-7 morphants 
(Figure 3.1G).  Furthermore, shape assessments determined these cells were rounded 
compared to the elongated shape of control ventricular myocytes (Figure 3.1H).  These 
results demonstrate that ventricular cardiomyocytes in 3-OST-7 morphants do not 
undergo the cell morphological change that is one of the hallmarks of ventricular 
maturation.   
3-OST-7-controlled ventricular contraction is not regulated by  
FGF and Notch signaling pathways 
To elucidate the pathways involved in 3-OST-7 regulation of ventricular 
maturation and contraction, we started with two major developmental signaling pathways 
as candidates, FGF and Notch signaling.  FGF was the first growth factor shown to 
require GAG chains for receptor-ligand complex formation and in vivo studies have 
highlighted the role of GAG chains in FGF signaling (Yayon et al., 1991; Pellegrini et al., 
2000; Schlessinger et al., 2000; Lin, 2004).  If loss of 3-O-sulfation caused by 
knockdown of 3-OST-7 perturbs FGF signaling, loss of FGF signaling should mimic the 
noncontracting ventricle phenotype of 3-OST-7 morphants.  To test this, we knocked 
down FGF receptor 1 (FGFR1) using morpholino in zebrafish embryos.  Knocking down 
FGFR1 resulted in ventricles that were smaller but still retained their ability to contract 
(Figure 3.2A).  This is consistent with reports wherein abolishing FGF signaling either by 
using the zebrafish fgf8/ace mutant or treatment with the FGFR inhibitor SU5402 also 
resulted in small hearts with particularly notable reductions of the ventricle (Reifers et al., 
2000; Marques et al., 2008).  The distinct phenotype suggest that the FGF signaling 
pathway is not downstream of 3-OST-7-catalyzed 3-O-sulfation.   
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In Drosophila, 3-O-sulfation by 3-OST-B has been implicated to play an 
important role in the Notch pathway (Kamimura et al., 2004).  More importantly, deltaD, 
a Notch ligand, was one of the most downregulated genes in microarray analysis  
comparing control embryo hearts and 3-OST-7 morphant hearts at 48 hpf (data not 
shown).  To determine whether 3-OST-7 regulates ventricular contraction by way of the 
Notch signaling pathway, we assessed whether the noncontracting ventricle phenotype is 
recapitulated in deltaD/aeiAG49 mutant embryos (Holley et al., 2000).  Embryos carrying a 
homozygous mutation in the deltaD gene were identified by misformed somites posterior 
to the ninth somite (Holley et al., 2000) and separated from wild-type or heterozygous 
siblings at 18 hpf.  The hearts were then scored for ventricular contraction at 48 hpf.  The 
hearts of deltaD/aeiAG49 mutants contracted similar to hearts of siblings (n=34 with 
perturbed somite patterning (mutants); n=94 rest of the clutch (wild-type siblings)).  
Since DeltaD is one of four Delta ligands in zebrafish, it is possible that other Delta 
ligands might be compensating for loss of DeltaD in deltaD/aeiAG49 mutants and masking 
effects on ventricular contraction.  To circumvent this, we used DAPT, a !-secretase 
inhibitor of all Notch signaling.  Treatment from 5 hpf, the time when cells are fated to 
become myocytes (Stainier et al., 1993), to 48 hpf, the time when the 3-OST-7 
noncontracting ventricle phenotype is clearly manifest, did not result in ventricular 
noncontraction (Figure 3.2B).  Similar observations were made when the treatment was 
started later, either at 15 hpf or 24 hpf (Figure 3.2B).  Together these results demonstrate 










Figure 3.2.  Disrupting the FGF and Notch signaling pathways do not phenocopy the 
noncontracting ventricle phenotype of 3-OST-7 knockdown. (A) Table showing 
percentage of normal contraction and small ventricles in control (uninjected) embryos, 
embryos injected with 4 ng fgfr1 MO1, and embryos injected with 8 ng fgfr1 MO2 at 48 
hpf.  Ventricular contraction appeared normal in all groups.  (B) Timeline showing the 
time and duration of 75 µM DAPT treatment and table showing percentage of embryos 
with normal contraction.  Control embryos were treated with 0.3%(v/v) DMSO.  
Ventricular contraction appeared normal in all treatments.  To ensure the DAPT was 
working, embryos treated with DAPT starting at 5 hpf were observed at 18 hpf for somite 





















3-OST-7 is required for normal region-specific 
 gene expression of bmp4 and versican 
In addition to the cardiomyocyte shape change, the cardiac maturation program 
also involves genes that become differentially expressed in a spatial and temporal 
manner.  Bmp4, versican, and notch1b are progressively restricted during heart 
development.  At 24 hpf, all three genes are expressed along the antero-posterior length 
of the heart, and are subsequently restricted to the atrioventricular (AV) canal by 48 hpf 
(Westin and Lardelli, 1997; Walsh and Stainier, 2001; Beis et al., 2005) and excluded 
from expression in the maturing ventricle.  In contrast in 3-OST-7 morphants, bmp4 and 
versican were ectopically expressed in ventricle at 48 hpf (Figure 3.3B and Figure 3.3D), 
whereas both are restricted to the AV canal and excluded from ventricle in control 
embryos (Figure 3.3A and 3.3C).  Bmp4 and versican remained ectopically expressed in 
ventricle cardiomyocytes at 3 days postfertilization (data not shown).  In contrast to bmp4 
and versican, notch1B was expressed solely in the AV canal for 3-OST-7 morphants 
(Figure 3.3F) similar to control embryos (Figure 3.3E), and tie2 expression, assessed in 
Tg(tie2:EGFP) embryos, was expressed normally in the AV canal in both control and 3-
OST-7 morphant embryos (Figure 3.3G and 3.3H), suggesting that the failure of bmp4 
and versican to become AV canal-restricted was not merely due to developmental delay.  
Together these results indicate the differentiation program does not occur completely in 
3-OST-7 morphants. Moreover, the observation that notch1B expression was normal in 3-
OST-7 morphants is consistent with our finding that the Notch pathway is not involved in 











Figure 3.3.  3-OST-7 regulates expression of myocardial genes bmp4 and versican at 48 
hpf.  In situ hybridization for bmp4 (A and B), versican (C and D), and notch1B (E and 
F) shows bmp4 and versican were ectopically expressed in ventricular myocardium of 3-
OST-7 morphants (B and D), whereas notch1B was restricted to AV endocardium (F).  
Control group (A, C and E) were injected with control 3-OST-5 MO.  Tie2 expression, 
assessed in Tg(tie2:EGFP) embryos, was normally expressed in 3-OST-7 morphant AV 
endocardium (G).   Control (F) was uninjected embryo.  V, ventricle; At, atrium; red 
















Myocardial contraction excludes bmp4 from the ventricle 
 The observations that bmp4 and versican were ectopically expressed in the 
ventricular myocardium, while notch1B and tie2 were normally expressed in the 
endocardium at the AV canal, suggest that 3-OST-7 morphants have a maturation defect 
that is specific to ventricular myocardium.  Moreover, these observations suggest ectopic 
bmp4 expression in the ventricular myocardium could be a result of ventricular 
noncontraction.  To determine whether ectopic expression of bmp4 and versican is due to 
noncontraction, we examined two other contractility morphants and assessed whether 
bmp4 expression in these mutants is similar to that of 3-OST-7 morphants.  We used 
morpholinos against the potassium channel gene kcnh2 and sarcomeric protein cardiac 
troponin T gene tnnt2.  Kcnh2 and tnnt2 mutants both have “silent” (i.e., noncontracting) 
hearts and morpholino knockdown of these genes phenocopy the mutant phenotypes 
(Sehnert et al., 2002; Arnaout et al., 2007).   
We examined bmp4 expression in the kcnh2 and tnnt2 morphants and classified it 
to be one of three:  normal, AV-restricted expression (AV only, green bar in Figure 
3.4B), ectopically expressed in ventricle (AV + V, red bar in Figure 3.4B), and 
ectopically expressed in atrium and ventricle (AV + V + At, blue bar in Figure 3.4B).  
Strikingly, bmp4 was ectopically expressed in kcnh2 and tnnt2 morphants (Figure 3.4B).  
Only 23.4% and 5.7% of embryos had normal AV-restricted expression with injection of 
kcnh2 and tnnt2 MO, respectively (green bars in Figure 3.4B), whereas a large fraction of 
embryos, 76.6% and 94.3% for kcnh2 and tnnt2 morphants, respectively, had ectopic 
expression (red and blue bars in Figure 3.4B).   
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Moreover, the fraction of embryos with ectopic bmp4 expression was larger in 
kcnh2 and tnnt2 morphants than in 3-OST-7 morphants.  Interestingly, the percentage of 
ectopic bmp4 expression correlated with percentage of noncontraction (Figure 3.4A and 
3.4B).  For example, knockdown of 3-OST-7 resulted in 56.9% of embryos having 
ventricular noncontraction (Figure 3.4A) and 48.8% had ectopic bmp4 expression (red 
and blue bars, Figure 3.4B), the least noncontraction and ectopic bmp4 expression 
fractions observed among the three MO knockdowns.  In contrast, knockdown of tnnt2 
resulted in 99.4% of embryos with noncontraction (Figure 3.4A), the highest 
noncontraction fraction among the three knockdowns, which correlated with the highest 
fraction of ectopic bmp4 expression (red and blue bars, Figure 3.4B).  These results 
suggest contraction is required for restricting bmp4 expression to the AV canal and 
excluding it from the ventricle and atrium.   
Next we asked whether this apparent effect of contraction on bmp4 expression is 
affecting the transition of ventricular cardiomyocytes from isometric morphology to 
elongated morphology.   We utilized the same technique we used for tracing ventricular 
cardiomyocyte outlines in 3-OST-7 morphants (Figure 3.1A and 3.1D) and used 
morphometric analysis to compare surface areas and shapes.  The surface area of 
ventricular cardiomyocytes was significantly reduced in kcnh2 and tnnt2 morphants, but 
not to the extent it was observed in 3-OST-7 morphants (Figure 3.4C).  Notably, 
ventricular cardiomyocytes were elongated in kcnh2 and tnnt2 morphants (Figure 3.4D).  
This suggests that the cardiomyocyte morphological defect observed in 3-OST-7 
morphants is not a secondary effect that could be generalized for noncontraction resulting 





Figure 3.4.  Contraction is correlated with ectopic bmp4 expression, whereas cell 
morphological change is dependent on regulation of contraction by 3-OST-7.  (A) Graph 
comparing the penetrance of noncontraction phenotype with 3-OST-7, kcnh2, and tnnt2 
MO injections.  (B) Graph comparing patterns of bmp4 expression at 48 hpf between 
control embryos (injected with 3-OST-5 MO), 3-OST-7 morphants, kchn2 morphants, 
and tnnt2 morphants.  Instead of normal expression at the AV canal (AV only), loss of 
contraction leads to ectopic bmp4 expression in the ventricle (AV + V) or throughout the 
heart (AV + V + At) in 3-OST-7, kcnh2 and tnnt2 morphants.  (C) Graph comparing cell 
surface area (µm2) measurements for control embryos (injected with 3-OST-3Z MO), 3-
OST-7 morphants, kcnh2 morphants, and tnnt2 morphants.  Surface areas were 
significantly smaller in 3-OST-7, kcnh2, and tnnt2 morphants than in control embryos 
(P<1.0x10-4 for control and 3-OST-7, P<3.0x10-2 for control and kcnh2, P<1.0x10-2 for 
control and tnnt2).  (D) Graph showing comparison of circularity measurements for 
control (injected with 3-OST-3Z MO), 3-OST-7 morphants, kcnh2, and tnnt2 morphants. 
Ventricular cardiomyocytes in 3-OST-7 morphants were more rounded than those in 
control embryos (P<4.0x10-3), whereas ventricular cardiomyocytes in kcnh2 and tnnt2 
morphants were as elongated as those in control (P<6.2x10-2 for control and kcnh2, 











Ectopic bmp4 expression in 3-OST-7 morphants  
is not due to general patterning defect 
 The restriction of bmp4 in the AV canal is part of a more comprehensive 
patterning of myocardial cells that have undergone the early stages of differentiation into 
either chamber myocardium (atrium or ventricle) or nonchamber myocardium (sinus 
venosus, AV canal, and outflow tract) (Harvey et al., 2009; Evans et al., 2010).  To 
determine whether ectopic bmp4 expression in 3-OST-7 morphants is a result of defects 
in patterning the chamber and nonchamber myocardium, we performed in situ 
hybridization for tbx2 (tbx2b in zebrafish) and anf in 48 hpf control embryos and 3-OST-
7 morphants.  Tbx2b is normally expressed in the AV canal (nonchamber myocardium) at 
48 hpf (Chi et al., 2008), and we observed a similar pattern of expression in both control 
embryos and 3-OST-7 morphants (Figure 3.5A and 3.5B).  Similarly, anf, which is 
normally expressed in atrium and ventricle (chamber myocardium) at 48 hpf (Figure 
3.5C), had a similar pattern of expression in 3-OST-7 morphants (Figure 3.5D).  Together 
these results suggest that ectopic bmp4 expression in the ventricle of 3-OST-7 morphants 
is not due to a general defect in patterning chamber and nonchamber myocardium. 
3-OST-7-mediated regulation of bmp4 expression  
feeds back to contraction 
 Expression of bmp4 has been used extensively as a marker for normal AV 
patterning in zebrafish, with ectopic expression correlated with defects in valve 
formation.  Whether this ectopic expression leads to other defects in those regions where 
it is ectopically expressed has not been elucidated.  We hypothesize that the ectopic 











Figure 3.5.  Chamber (working) and nonchamber (nonworking) myocardium appear 
delineated in 3-OST-7 morphants.  In situ hybridization for tbx2b (A and B), a 
nonchamber myocardium-specific marker, and anf (C and D), a chamber myocardium-
specific marker, suggests delineation between chamber and nonchamber myocardium 
occurs normally in 3-OST-7 morphants.  Control (A and B) are embryos injected with 


























this, we utilized the zebrafish bmp4st72 mutant (Stickney et al., 2007) and asked whether 
reduction of bmp4 will rescue the noncontracting ventricle phenotype caused by 
knockdown of 3-OST-7.  We injected 3-OST-7 MO into embryos from crosses between 
bmp4st72/+ heterozygotes, with uninjected embryos from the same genetic crosses serving 
as control.  The embryos were then segregated by heart phenotype: normal hearts, AV 
defects, or noncontracting ventricles at 48 hpf.  The AV defect is characterized by an 
obscure boundary between atrium and ventricle (data not shown).  The embryos were 
then individually genotyped.  In uninjected embryos (n=163), the noncontracting 
ventricle phenotype was not observed for bmp4st72 mutants.  The percentage of embryos  
with the noncontracting ventricle phenotype, observed at 62.5% of 3-OST-7 MO injected 
wild-type siblings (+/+), was reduced for 3-OST-7 MO injected bmp4st72 mutants (-/-), 
with only 10% of these mutants having a noncontracting ventricle (n=55 for 3-OST-7 
MO injected embryos) (Figure 3.6).  Genomic DNA of the injected bmp4st72 mutants 
were sequenced to determine whether each contains the correct target site for the 3-OST-
7 MO.  This is to confirm that the 3-OST-7 MO sequence was targeting 3-OST-7 in the 
bmp4st72 mutant line.   
This demonstrates that ectopic expression of bmp4 exacerbates the noncontracting 
ventricle phenotype of 3-OST-7 morphants, because elimination of bmp4 expression 
through the bmp4st72 mutant resulted in the rescue of the noncontracting ventricle 
phenotype.  Furthermore this demonstrates that 3-OST-7 and bmp4 act in a feedback loop 














Figure 3.6.  Ventricular noncontraction is rescued in 3-OST-7 morphants by bmp4st72 
mutation.  Graphs depicting the percentage of embryos with noncontracting ventricle 
(red) or defective AV (green) in three genotypic classes of uninjected bmp4st72 embryos 






















 The function of the heart begins before it has completed developing, prompting 
the question of whether contraction is required for the differentiation events that occur 
after the heart starts beating.  Although the relationship of structure and function in heart 
development has been addressed in previous studies (Bartman et al., 2004; Bartman and 
Hove, 2005; Auman et al., 2007), questions remain as to which pathways mediate this 
relationship. 
 In this study we demonstrate that contractility has a novel and highly specific 
function in gene expression.  Knockdown of 3-OST-7 eliminates ventricular contraction 
and results in failure of ventricular cardiomyocytes to transition from isometric to 
elongated cell shape and in ectopic expression of bmp4 and versican in the ventricle.  By  
in situ hybridization for markers of the endocardium, chamber myocardium, and 
nonchamber myocardium, the defects in morphogenesis and gene expression do not 
appear to be due to a general defect in differentiation.  Strikingly, knockdowns of two 
other genes, kcnh2 and tnnt2, which eliminate contraction by distinct pathways, also 
resulted in ectopic expression of bmp4 in the ventricle.  Notably, percentage of embryos 
with ectopic expression of bmp4 is correlated with the penetrance of noncontraction with 
the MO knockdown.  To illustrate, knockdown of 3-OST-7 MO had the least percentage 
of embryos with ectopic bmp4 expression and also had the least penetrant noncontraction 
phenotype, whereas knockdown of tnnt2 had the most fraction of embryos with ectopic 
bmp4 expression and also the most penetrant noncontraction phenotype.  Our findings 
support the concept that myocardial function affects differentiation processes occurring 
after the first heartbeat, and demonstrate that defective contraction alters bmp4 
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expression.  In contrast to the correlation between contraction and bmp4 expression, the 
transition from isometric to elongated cell shape appears relatively normal in kcnh2 and 
tnnt2 morphants, suggesting that this cellular phenotype could not be generalized for all 
contractility defects, but is a result of noncontraction specific to 3-OST-7 knockdown.  
 Another intriguing question is whether ectopic bmp4 expression in the ventricle 
leads to defects specific to the ventricle.  Strikingly, ventricular noncontraction is rescued 
in 3-OST-7 morphants by bmp4st72 mutation, suggesting 3-OST-7 and bmp4 are in a 
feedback loop that controls contraction.  We hypothesize 3-OST-7 might function in two 
modes in this pathway (Figure 3.7).  First, 3-OST-7 allows for normal ventricular 
contraction (1 in Figure 3.7), which then inhibits expression of bmp4 in the ventricle (2 in 
Figure 3.7).  This is supported by our data on the tight correlation between three distinct  
pathways that eliminate contraction (knockdown of 3-OST-7, kcnh2 or tnnt2) and 
corresponding ectopic bmp4 expression in the ventricle.  Second, HSPGs that are 
specifically modified by 3-OST-7 might inhibit expression of bmp4 in the ventricle (3 in 
Figure 3.7) and this inhibition blocks the inhibitory action of bmp4 on contraction (4 in 
Figure 3.7), allowing normal ventricular contraction.  Intersection of these two modes of 
action result in a feedback loop, which is supported by our finding that 3-OST-7 
knockdown-induced ventricular noncontraction can be rescued back to normal 
contraction in bmp4st72 mutants.   
Determining the signaling pathways that mediate 3-OST-7 regulation of bmp4 
expression and contraction would help us elucidate this feedback loop.  Our findings that 
perturbation of the FGF and Notch signaling pathways did not result in ventricular 












Figure 3.7.  Model for role of 3-OST-7 in regulating a feedback loop between bmp4 
expression and cardiomyocyte contraction.  For the heart to develop normally, 3-OST-7 
functions in a feedback loop to regulate both contraction and inhibition of bmp4 


























suggest that these pathways are not involved in 3-OST-7 regulation of contraction.  
However, we could not discount the possibility that 3-OST-7 modulates multiple 
pathways to regulate contraction.  With regards to 3-OST-7 regulation of bmp4 
expression, it could occur directly by interaction of 3-OST-7-modified HSPGs with 
Bmp4 protein, leading to bmp4 feedback inhibition of its own expression and inhibiting 
subsequent expression of bmp4 in ventricle.  In this direct interaction scenario, 
knockdown of 3-OST-7 leads to derepression of Bmp4 functions, including suppression 
of contraction and hyperactivation of BMP signaling, and leads to increased bmp4 
expression.  The alternative possibility is that 3-OST-7 is modulating another pathway 
that inhibits bmp4 expression in the ventricle. 
 The zebrafish 3-OST-7 knockdown model provides an outstanding system to 
study the relationship between structure and function.  Our study demonstrates that 3-
OST-7 regulates both contraction and bmp4 expression in the ventricle, and that each of 
these processes are tightly linked in a feedback loop.  We anticipate that further 
investigation of this feedback loop between contraction and gene expression, with regards 
to defining the pathways that mediate them, will greatly improve our understanding of 
cardiac morphogenesis and will continue to highlight the significance of 3-O-sulfation in 
cardiac development, physiology and function. 
Materials and methods 
Zebrafish strains and lines 
Zebrafish were maintained under standard laboratory conditions at 28.5°C.  In 
addition to Oregon AB wild-type, the transgenic Tg(cmlc2-DsRed-nuc) (Mably et al., 
2003) and Tg(tie2:EGFP) zebrafish (Motoike et al., 2000), and the zebrafish 
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deltaD/aeiAG49 (Holley et al., 2000) and bmp4st72 (Stickney et al., 2007) mutants were 
used. 
Morpholino injection 
Antisense MOs were obtained from Gene Tools, LLC.  The following morpholino 
oligonucleotides and their corresponding concentrations were used: translation-blocking 
3-OST-7 MO (5’-CACATAACTCAGAAGATTGGCCATG-3’, 5.4 ng); translation-
blocking 3-carboxyfluorescein-labelled FGFR1 MO1 (5’-
GCAGCAGCGTGGTCTTCATTATCAT-3’, 4 ng) (Scholpp et al., 2004; Thummel et al., 
2006) and translation-blocking 3-carboxyfluorescein-labelled FGFR1 MO2 (5’-
CAAAGATCCTCTACATCTGAACTCC-3’, 8 ng) (Thummel et al., 2006); translation-
blocking kcnh2 MO (5’-CGCGTGGACAGATTCAAGAGCCCTC-3’, 2.3 ng)(Arnaout et 
al., 2007); translation-blocking tnnt2 MO (5!-CATGTTTGCTCTGATCTGACACGCA-
3!, 4 ng) (Sehnert et al., 2002); and 3-OST-5 MO (5’-
GTCCAGTCAGGTCAAGGGCAGCTCA-3’, 2.7 ng) and 3-OST-3Z MO (5’-
GTCCAGTCAGGTCAAGGGCAGCTCA-3’, 5.4 ng) as control MOs;  Embryos were 
injected at the 1-2 cell stage.  
DAPT treatment 
 A 25 mM stock of DAPT (Calbiochem) in DMSO was diluted in E3 medium.  
Embryos were incubated in 75 uM in E3 medium and control embryos were incubated in 
0.3% DMSO in E3 medium at 5 hpf, 15 hpf, and 24 hpf.  Ventricular contraction was 
assessed at 48 hpf.  Two other incubation periods, one starting at 5 hpf and ending at 24 
hpf and the second starting at 15 hpf and ending at 24 hpf, were used.  For embryos 
treated at 5 hpf, somite formation was assessed at 18 hpf to ensure DAPT treatment was 
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working.   
In situ hybridization 
 Digoxigenin-labeled antisense riboprobes were synthesized using Digoxigenin 
RNA Labeling Kit (Roche).  cDNA plasmids encoding bmp4, versican, notch1B (a gift 
from Priya Choudhry), anf, and tbx2b were used.  In situ hybridizations were performed 
as previously described (Essner et al., 2000), with anti-digoxigenin antibody incubation 
carried out using a Biolane HTI machine.  Embryos were cleared in 70% glycerol and 
photographed with a Nikon SMZ1000 camera.  Digital images were processed with 
Adobe Photoshop CS4.  
Immunohistochemistry 
Immunohistochemistry using the primary antibodies anti-!-catenin (1:200) and 
anti-DsRed (1:200) was performed as described previously (Neugebauer et al., 2009).  
Secondary antibodies used were goat anti-mouse Alexa Fluor 488 (Molecular Probes) 
and donkey anti-rabbit Alexa Fluor 568 (Molecular Probes) in 1:100 dilution.  Images 
were acquired using an Olympus Fluoview FV300 laser scanning confocal microscope.  
Digital images were processed with Adobe Photoshop CS4. 
Rescue in bmp4st72 embryos 
 Embryos from bmp4st72/+ x bmp4st72/+ matings were injected with 3-OST-7 MO.  
At 48 hpf, the hearts were scored for noncontracting ventricle, AV defect, or wild-type 
phenotype.  Genomic DNA was extracted from each individual embryo and genotyped 
using the following dCAPS primers, 5’-TGGTGAGGCACAACACCTCCAACTAG-3’ 
(forward) and 5’-CCGAGTCAGCGGGTGACTTTTGCCGTC-3’ (reverse) (generous 
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gifts from Renee Bend).  The PCR products were digested with SpeI (NEB) and ran in 
3% agarose gel.  Digestion with SpeI releases 250 bp band in wild-type, 230 bp band in 
mutant, and both in heterozygotes.  DNA genotyped to be from mutants were sequenced 
to verify compatibility with 3-OST-7 MO. 
Cell morphometrics 
 ImageJ software (NIH) was used to trace cell outlines based on anti-!-catenin 
staining and to measure the cell surface areas and circularities.  Five cells, whose outlines 
were clearly distinct, were chosen for measurements from each of 10 embryos in each 
injection group.  Circularity was computed by ImageJ using the formula 4"A/P2.  It is a 
normalized ratio of area (A) to perimeter (P), with a ratio of 1 representing a perfect 
circle.  The circularity values distinguished cells with rounded surfaces from those with 
elongated surfaces. 
Statistics 
 For comparing cell surface areas and circularity, unpaired t-test was used using 
GraphPad Prism (version 5.00 for Mac GraphPad Software). 
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 DISCUSSION  
In this study we have determined the roles of 3-O-sulfotransferase-7 in zebrafish 
heart development and have uncovered a knockdown model in which to study the 
relationship between structure and function.  3-OST-7 is required for transcription and 
accumulation of tropomyosin4 (tpm4) mRNA in the ventricle, ensuring normal levels of 
Tpm4 and other sarcomeric proteins are present to assemble the sarcomere.  Moreover, 3-
OST-7 controls a feedback loop between BMP signaling and contraction.  In the 
knockdown model of 3-OST-7, contraction was demonstrated to regulate bmp4 
expression in the ventricle and the transition from isometric to elongated cell shape, both 
of which are important processes in ventricle maturation. 
HSPG modulate processes in cardiac development 
The developmental process by which the heart transforms from a bilateral set of 
precursor cells to the mature, beating organ is orchestrated by a network of growth 
factors, morphogens, and transcription factor families.  Members of this signaling 
network could act differentially depending upon specific spatiotemporal cues.  That 
heparan sulfate proteoglycans (HSPGs) provide part of these spatiotemporal cues is what 
I addressed in this dissertation. 
The location of HSPGs, on the cell surface or in the extracellular matrix, and their 
structural heterogeneity place them at a unique advantage to influence signaling pathways 
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and cell-cell or cell-matrix interactions (Esko and Lindahl, 2001).  This versatility has 
been demonstrated in various animal models where genes coding for the core proteins 
and proteins involved in biosynthesis and modification of HSPGs have been knocked out 
or knocked down (Bulow and Hobert, 2006).  Notably, two of these genes have been 
shown to be important at different steps of cardiac formation.   
The core protein syndecan 2 (Sdc2) acts in the extraembryonic yolk syncytial 
layer to direct the bilateral set of heart precursors to fuse (Arrington and Yost, 2009).  
This is postulated to occur by regulating fibronectin and laminin matrix assembly 
demonstrating how HSPGs mediate interactions between cells and their environments, 
interactions that are critical for organogenesis.  Meanwhile, UDP glucose dehydrogenase 
(UGDH), an enzyme involved in the synthesis of heparan sulfate, chondroitin sulfate and 
hyaluronic acid, is required for cardiac valve formation in zebrafish (Seidman and 
Seidman, 2001; Walsh and Stainier, 2001).  Interestingly, Sugarless, the Drosophila 
homolog of UGDH, has been shown to be important in the FGF and Wnt signaling 
pathways (Binari et al., 1997; Hacker et al., 1997; Haerry et al., 1997; Lin et al., 1999).  
This illustrates an essential role HSPGs play in transducing signals from extracellular 
ligands into the cell. 
The ability of HSPGs to modulate these processes are partly due to the 
glycosaminoglycan chains attached to the core proteins and their associated modifications 
(Esko and Selleck, 2002).  In this dissertation I examined the functions of 3-OST-7 in 
zebrafish heart development.  3-OST-7 is a member of the zebrafish 3-OST family, 
whose expression patterns suggest distinct roles in the developing embryo (Cadwallader 
and Yost, 2006).  Knockdown of 3-OST-7 resulted in a noncontracting ventricle where 
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contraction has been uncoupled from excitation because of sarcomere defects.  
Additionally, knockdown of 3-OST-7 uncovered a feedback loop between bmp4 
expression and contraction, making this a favorable model for studying the relationship 
between structure and function. 
3-OST-7 controls ventricular contraction 
Contraction of the heart is downstream of excitation events that transduce the 
electrical stimulus from the sinus venosus to the atrium and then to the ventricle.  Cardiac 
excitation events, specifically the generation of action potentials and calcium transients, 
were demonstrated to be normal in 3-OST-7 morphant atrium and ventricle.  In contrast, 
ventricular contraction was defective.  The spatiotemporal specificity of this phenotype 
highlights the level of specificity of 3-OST-7-dependent 3-O-sulfation.  The ubiquitous 
expression of 3-OST-7 (Cadwallader and Yost, 2006) suggests it functions in all tissues.  
However, it appears dispensable in other tissues but is strictly required in the ventricle, 
since knockdown of 3-OST-7 resulted in a ventricle-specific defect.  Moreover, rescue of 
the noncontracting ventricle in transgenic Tg(!-actin:3-OST-7-IRES-EGFP) embryo, 
which ubiquitously overexpresses 3-OST-7, and not in Tg(cmlc2:3-OST-7-IRES-EGFP), 
which overexpresses 3-OST-7 only in the myocardium, suggests 3-OST-7 is required in a 
neighboring, non-cmlc2 expressing tissue.  Another possibility is that the timing of the 
cmlc2-driven transgene is off, which still underscores the importance of temporal 
specificity for 3-OST-7 activity in ventricular contraction.  It would be interesting to see 
whether the use of other cardiac-specific drivers that will overexpress 3-OST-7 in other 
cardiac tissues such as the endocardium and the epicardium will rescue ventricular 
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noncontraction.  This will elucidate the intricacy of interactions among cardiac tissues 
required for normal cardiac function and development. 
3-OST-7 controls myofibrillogenesis 
For normal heart contraction to occur, contractile proteins must be produced and 
assembled in units called sarcomeres.  This process termed myofibrillogenesis gives rise 
to a thick filament system, composed mostly of myosin, and a thin filament system, 
consisting of actin, troponin, and tropomyosin.  The highly organized sarcomere ensures 
coordinated generation of force from regulated interaction of actin and myosin filaments.  
Knockdown of 3-OST-7 interferes with the process of myofibrillogenesis as assessed by 
appearance of aberrant sarcomeric proteins from immunohistochemical staining of actin, 
cardiac troponin T (Tnnt2), and Tpm.  Our findings support the concept that loss of a 
sarcomere protein impacts on the stability of other sarcomere proteins and the sarcomere 
as a whole, because strikingly, only tpm4 transcripts were reduced in 3-OST-7 
morphants.  More importantly, overexpression of Tpm4 protein by injection of tpm4 
RNA, rescued the noncontracting ventricle.  This suggests Tpm4 acts as a lynchpin 
protein and that normal levels of Tpm4 stabilize Tnnt2 and possibly another tropomyosin 
protein, Tpma (Zhao et al., 2008).  Moreover, the resulting reduction of Tnnt2 could 
likewise affect Tpm and other sarcomere proteins such as TnI (Sehnert et al., 2002).  
These indicate the existence of a feedback mechanism to ensure proteins within a 
sarcomere are stabilized in a coordinated manner.  
Our findings also demonstrate that ventricular contraction does not occur 
normally in 3-OST-7 morphants because contraction is uncoupled from excitation, 
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placing 3-OST-7 dependent 3-O-sulfation in a novel pathway that regulates 
myofibrillogenesis. 
3-OST-7 controls morphogenesis 
Transitioning from an isometric to an elongated morphology is one of the 
hallmarks of ventricular myocyte maturation (Auman et al., 2007).  Knockdown of 3-
OST-7 perturbed this morphogenetic process, resulting in isometric ventricular 
cardiomyocytes that differ from ventricular myocytes found in normal embryos of the 
same stage.   The defect in morphogenesis is not due to an overall defect in maturation 
because markers for the chamber (working) myocardium, nonchamber (nonworking) 
myocardium, and the endocardium were normally expressed.   
The relationship between structure and function is a popular theme in heart 
development (Bartman et al., 2004; Bartman and Hove, 2005; Auman et al., 2007).  
Because the heart starts to beat even before it completes its formation, possibly affecting 
subsequent processes of differentiation, the observed failure of ventricular 
cardiomyocytes to elongate could be a result of ventricular noncontraction.  Since we 
have shown tpm4 is downstream of 3-OST-7 in regulating contraction, it would be 
interesting to see whether tpm4 mutants and morphants possess the same isometric 
ventricular cardiomyocytes as 3-OST-7 morphants.  Interestingly, the isometric 
cardiomyocyte morphology observed in 3-OST-7 morphants was not observed in two 
distinct contraction defect models, kcnh2 and tnnt2 morphants, however ventricular 
cardiomyocytes in these two morphants had subtle differences from control 
cardiomyocytes.  This suggests that the relationship between structure and function is 
complex and is dependent on the pathway that perturbs contraction.  It also supports 
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previous studies where the use of zebrafish mutants have demonstrated that contractility 
and blood flow have contrasting effects on cardiomyocyte dimensions (Auman et al., 
2007). 
3-OST-7 controls a feedback loop between  
bmp4 signaling and contraction 
 Restriction of genes to specific regions of the heart is part of the sub-
specialization process the heart undergoes during its maturation (Evans et al., 2010).  
Knockdown of 3-OST-7 resulted in ectopic expression of bmp4 and versican in the 
ventricle.  This ectopic expression appeared to be due to ventricular noncontraction 
because noncontraction and ectopic bmp4 expression were correlated in kcnh2 and tnnt2 
morphants as well.  Strikingly, ventricular noncontraction in 3-OST-7 morphants was 
rescued by the bmp4st72 mutation.  This suggests a feedback loop exists between bmp4 
signaling and contraction and that this feedback loop is controlled by 3-OST-7.  I 
anticipate that defining the pathways that mediate this feedback loop will greatly improve 
our understanding of cardiac morphogenesis and will continue to highlight the 
significance of 3-OST-7 dependent 3-O-sulfation in cardiac development, physiology and 
function. 
Role of signaling pathways in transducing 3-OST-7 signal 
 Experiments that sought to perturb the FGF and Notch signaling pathways have 
demonstrated that these pathways are not likely transducing the 3-OST-7 signal.  
However, it is likely that these pathways act in concert to regulate ventricular contraction 
and a more global strategy is required to tease apart these interactions.  In line with this, 
we performed microarray analysis to determine the differences in transcription profiles 
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between wild-type and 3-OST-7 morphant hearts and to possibly identify signaling 
pathways that we have not looked at previously.  Using t-test to identify statistically 
significant profiles, 727 genes were shown to be down-regulated and 1823 were up-
regulated.  The most dramatically regulated genes were not known members of major 
developmental signaling pathways.  Future gene ontology analysis or analysis based on 
grouping genes by their functions might improve identification of relevant genes.  
Role of core proteins in cardiac development 
This dissertation has primarily focused on 3-OST-7 dependent modification of 
GAG chains, but an important aspect of modulation by HSPGs is through their core 
proteins (Esko and Selleck, 2002).   Knockdown of Sdc2 has demonstrated a core protein 
could act in a specific step of cardiac formation (Arrington and Yost, 2009).  It would be 
interesting to know which core proteins, when mutated or knocked down, give a similar 
phenotype as knockdown of 3-OST-7.  Although knockdown of Sdc2 does not give a 
cardiac phenotype similar to knockdown of 3-OST-7 (unpublished data, personal 
communications with C.B. Arrington), there are three more syndecans and 10 glypicans 
that could be acting independently or in concert to ensure normal cardiac function. 
Role of other 3-OSTs in cardiac development 
 3-OST-7 is one of eight 3-OSTs in zebrafish, making it possible there are other 3-
OSTs involved in heart development.  We have explored this possibility by knocking 
down several other members of the 3-OST family, and found that only one other member, 
3-OST-1, the closest relative of 3-OST-7, has a similar cardiac phenotype as knockdown 
of 3-OST-7.  Both knockdowns resulted in similar penetrance of ventricular 
noncontraction.  Furthermore, double knockdown of 3-OST-7 and 3-OST-1 increased 
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penetrance of the cardiac ventricular phenotype, arguing that these two 3-OSTs are 
partially functionally redundant.  It would be interesting to see whether ventricular 
noncontraction in 3-OST-7 morphants could be rescued by overexpression of 3-OST-1 
RNA.   Of interest too is whether these two 3-OSTs modulate the same pathways to 
affect ventricular contraction.  Interestingly, knockdown of 3-OST-1 has a more severe 
effect on the heart, including defects in atrial contraction, suggesting 3-OST-1 regulates 
other aspects of cardiac formation.  Further exploration of the cardiac phenotype in 3-
OST-1 morphants will help elucidate the unique roles of 3-OST-1. 
Conclusion 
 I have demonstrated in this dissertation that 3-OST-7 regulates novel processes of 
cardiac development.  3-OST-7 controls ventricular contraction by controlling 
myofibrillogenesis and mediates structure-function relationships by controlling bmp4 
expression.  Further exploration of the 3-OST-7 knockdown model could uncover 
signaling mechanisms and transducers that regulate cardiac development and physiology. 
References 
Arrington CB, Yost HJ (2009) Extra-embryonic syndecan 2 regulates organ primordia 
migration and fibrillogenesis throughout the zebrafish embryo. Development 
136:3143-3152. 
Auman HJ, Coleman H, Riley HE, Olale F, Tsai HJ, Yelon D (2007) Functional 
modulation of cardiac form through regionally confined cell shape changes. PLoS 
Biol 5:e53. 
Bartman T, Hove J (2005) Mechanics and function in heart morphogenesis. Dev Dyn 
233:373-381. 
Bartman T, Walsh EC, Wen KK, McKane M, Ren J, Alexander J, Rubenstein PA, 
Stainier DY (2004) Early myocardial function affects endocardial cushion 
development in zebrafish. PLoS Biol 2:E129. 
 101 
Binari RC, Staveley BE, Johnson WA, Godavarti R, Sasisekharan R, Manoukian AS 
(1997) Genetic evidence that heparin-like glycosaminoglycans are involved in 
wingless signaling. Development 124:2623-2632. 
Bulow HE, Hobert O (2006) The molecular diversity of glycosaminoglycans shapes 
animal development. Annu Rev Cell Dev Biol 22:375-407. 
Cadwallader AB, Yost HJ (2006) Combinatorial expression patterns of heparan sulfate 
sulfotransferases in zebrafish: I. The 3-O-sulfotransferase family. Dev Dyn 
235:3423-3431. 
Esko JD, Lindahl U (2001) Molecular diversity of heparan sulfate. J Clin Invest 108:169-
173. 
Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in 
heparan sulfate. Annu Rev Biochem 71:435-471. 
Evans SM, Yelon D, Conlon FL, Kirby ML (2010) Myocardial lineage development. 
Circ Res 107:1428-1444. 
Hacker U, Lin X, Perrimon N (1997) The Drosophila sugarless gene modulates Wingless 
signaling and encodes an enzyme involved in polysaccharide biosynthesis. 
Development 124:3565-3573. 
Haerry TE, Heslip TR, Marsh JL, O'Connor MB (1997) Defects in glucuronate 
biosynthesis disrupt Wingless signaling in Drosophila. Development 124:3055-
3064. 
Lin X, Buff EM, Perrimon N, Michelson AM (1999) Heparan sulfate proteoglycans are 
essential for FGF receptor signaling during Drosophila embryonic development. 
Development 126:3715-3723. 
Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY (2002) Cardiac 
troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 
31:106-110. 
Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy: from mutation 
identification to mechanistic paradigms. Cell 104:557-567. 
Walsh EC, Stainier DY (2001) UDP-glucose dehydrogenase required for cardiac valve 
formation in zebrafish. Science 293:1670-1673. 
Zhao L, Zhao X, Tian T, Lu Q, Skrbo-Larssen N, Wu D, Kuang Z, Zheng X, Han Y, 
Yang S, Zhang C, Meng A (2008) Heart-specific isoform of tropomyosin4 is 
essential for heartbeat in zebrafish embryos. Cardiovasc Res 80:200-208. 
 
 
